News

American Strategic Investment Co. Announces Release Date for First Quarter Results

  • NEW YORK--(BUSINESS WIRE)--AMERICAN STRATEGIC INVESTMENT CO. ANNOUNCES RELEASE DATE FOR FIRST QUARTER RESULTS.
    04/24/2025

American Strategic Investment Co (NYC) Q4 2024 Earnings Call Transcript

  • American Strategic Investment Co (NYSE:NYC ) Q4 2024 Earnings Conference Call March 19, 2025 11:00 AM ET Company Participants Curtis Parker - Senior Vice President Michael Anderson - Chief Executive Officer Mike LeSanto - Chief Financial Officer Conference Call Participants Operator Good morning, and welcome to the American Strategic Investment Co.'s Fourth Quarter and Year End 2024 Earnings Call. All lines have been placed on mute to prevent any background noise.
    03/19/2025
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

New York City REIT, Inc. (NYC) can sell. Click on Rating Page for detail.

The price of New York City REIT, Inc. (NYC) is 11.465 and it was updated on 2025-05-09 01:11:35.

Currently New York City REIT, Inc. (NYC) is in undervalued.

News
    
News

American Strategic Investment Co. Announces Fourth Quarter 2024 Results

  • NEW YORK--(BUSINESS WIRE)--AMERICAN STRATEGIC INVESTMENT CO. ANNOUNCES FOURTH QUARTER 2024 RESULTS.
    Wed, Mar. 19, 2025

American Strategic Investment Co. Announces Release Date for Fourth Quarter and Full Year 2024 Results

  • NEW YORK--(BUSINESS WIRE)--AMERICAN STRATEGIC INVESTMENT CO. ANNOUNCES RELEASE DATE FOR FOURTH QUARTER AND FULL YEAR 2024 RESULTS.
    Fri, Mar. 07, 2025

NineDot Energy Announces $65 Million Equipment Financing

  • NEW YORK--(BUSINESS WIRE)-- #batterystorage--NineDot Energy®, the leading developer of community-scale battery energy storage systems (BESS) in the New York City metro area, today announced the closing of a $65 million equipment financing transaction led by First Citizens Bank, a leader in renewable energy finance. This financing supports the purchase of nearly 100 Megawatts (MW) / 400 Megawatt hours (MWh) of batteries for use in up to 20 battery storage projects across the New York City metro area. “NineDot has.
    Wed, Jan. 22, 2025

American Strategic Investment Co. Sets Closing Date for 9 Times Square Sale

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today that December 19, 2024, has been set as the closing date for the sale of its 9 Times Square Midtown Manhattan property (“9 Times Square”) for a contract sales price of $63.5 million. Additionally, in connection with this transaction, the buyer has paid a $7 million non-refundable deposit with respect to the sales price. The Company previously announced that it had secured an amendm.
    Tue, Dec. 10, 2024

All You Need to Know About American Strategic Investment Co. (NYC) Rating Upgrade to Buy

  • American Strategic Investment Co. (NYC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
    Fri, Nov. 22, 2024
Transcripts
Transcipts Data
SEC Filings
SEC Filings

New York City REIT, Inc. (NYC) - ARS

  • SEC Filings
  • 04/18/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/18/2025

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 04/17/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 04/17/2025

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 04/15/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/15/2025

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 04/14/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 04/14/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/10/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/07/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 04/04/2025

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 04/03/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 04/03/2025

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 04/02/2025

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 04/02/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/02/2025

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 04/01/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 04/01/2025

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 03/31/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/28/2025

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 03/26/2025

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 03/25/2025

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 03/25/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/25/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/25/2025

New York City REIT, Inc. (NYC) - 3

  • SEC Filings
  • 03/25/2025

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 03/24/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/24/2025

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 03/19/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/19/2025

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 03/17/2025

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 03/17/2025

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 03/11/2025

New York City REIT, Inc. (NYC) - AW

  • SEC Filings
  • 03/05/2025

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 02/28/2025

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 02/28/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/28/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/21/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/20/2025

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 02/19/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/19/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/19/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/13/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/07/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/06/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/04/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/30/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/27/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 01/23/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/23/2025

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 01/21/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 01/21/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/17/2025

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 01/16/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 01/16/2025

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 01/15/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/14/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/08/2025

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/03/2025

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 01/02/2025

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 01/02/2025

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 12/31/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/31/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 12/30/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 12/30/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 12/30/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 12/26/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/23/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 12/23/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/20/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/19/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 12/18/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 12/13/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 12/11/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 12/11/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 12/05/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/05/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 12/05/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 11/29/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 11/29/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 11/29/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 11/20/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 11/12/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 11/12/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 11/07/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 11/06/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 11/06/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 10/29/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 10/28/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 10/24/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 10/23/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 10/23/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 10/22/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 10/21/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 10/18/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 10/17/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 10/11/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 10/11/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 10/11/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 10/07/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 10/01/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 10/01/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 09/30/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 09/23/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 09/18/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 09/13/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 09/05/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 09/03/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 09/03/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 08/30/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 08/30/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 08/30/2024

New York City REIT, Inc. (NYC) - N-PX

  • SEC Filings
  • 08/27/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 08/21/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 08/16/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 08/15/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 08/12/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 08/12/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 08/01/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 08/01/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 08/01/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 07/24/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 07/18/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 07/18/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 07/18/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 07/17/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 07/16/2024

New York City REIT, Inc. (NYC) - N-14

  • SEC Filings
  • 07/09/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 07/09/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 07/03/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 07/02/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 07/01/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 07/01/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 06/28/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 06/28/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 06/28/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 06/28/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 06/26/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 06/26/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 06/26/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 06/24/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 06/18/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 06/18/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 06/13/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 06/12/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 06/11/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 06/11/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 06/07/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 06/03/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 06/03/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 05/29/2024

New York City REIT, Inc. (NYC) - 3/A

  • SEC Filings
  • 05/29/2024

New York City REIT, Inc. (NYC) - 3

  • SEC Filings
  • 05/29/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 05/24/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 05/23/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 05/23/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 05/22/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 05/22/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 05/20/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 05/03/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 05/03/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 04/30/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 04/30/2024

New York City REIT, Inc. (NYC) - ARS

  • SEC Filings
  • 04/17/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 04/08/2024

New York City REIT, Inc. (NYC) - 3

  • SEC Filings
  • 04/05/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/03/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 04/01/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/25/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 03/21/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 03/20/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/20/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 03/18/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/18/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 03/14/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 03/14/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/14/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 03/13/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/13/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 03/08/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 03/07/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/07/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/05/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 03/01/2024

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 03/01/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/01/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/22/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/16/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/13/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/09/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 02/01/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/01/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 01/29/2024

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 01/25/2024

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 01/18/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 01/18/2024

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/12/2024

New York City REIT, Inc. (NYC) - 3

  • SEC Filings
  • 01/08/2024

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 12/29/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/22/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 12/20/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/19/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 12/18/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/18/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 12/15/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/15/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/11/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 12/08/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/08/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 12/01/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 12/01/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/01/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 11/28/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 11/28/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 11/24/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 11/24/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 11/20/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 11/20/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 11/20/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 11/16/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 11/03/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 11/02/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 11/02/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 10/20/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 10/18/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 10/18/2023

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 10/17/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 10/16/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 10/13/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 10/13/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 10/11/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 10/11/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 10/06/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 10/06/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 10/05/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 10/02/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 09/22/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 09/20/2023

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 09/19/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 09/19/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 09/15/2023

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 09/13/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 09/13/2023

New York City REIT, Inc. (NYC) - 3

  • SEC Filings
  • 09/12/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 09/01/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 09/01/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 09/01/2023

New York City REIT, Inc. (NYC) - N-PX

  • SEC Filings
  • 08/25/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 08/24/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 08/18/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 08/15/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 08/14/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 08/03/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 08/03/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 08/01/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 08/01/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 07/17/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 07/17/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 07/14/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 07/14/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 07/12/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 07/03/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 06/30/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 06/30/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 06/30/2023

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 06/28/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 06/28/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 06/27/2023

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 06/22/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 06/22/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 06/22/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 06/22/2023

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 06/21/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 06/16/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 06/15/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 06/14/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 06/09/2023

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 06/07/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 06/07/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 06/06/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 06/02/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 06/02/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 06/01/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 06/01/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 05/26/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 05/23/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 05/19/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 05/19/2023

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 05/10/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 05/10/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 05/04/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 05/01/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 05/01/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/21/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 04/20/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 04/20/2023

New York City REIT, Inc. (NYC) - ARS

  • SEC Filings
  • 04/18/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/18/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/17/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/13/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/11/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 04/10/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 04/10/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 04/06/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/06/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 04/05/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/05/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/31/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/31/2023

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 03/29/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 03/29/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/29/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/27/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/24/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/23/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/21/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 03/17/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/08/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 03/02/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/02/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 03/01/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 03/01/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 03/01/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/01/2023

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 02/23/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 02/23/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/23/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 02/17/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/17/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 02/16/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/16/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 02/15/2023

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 02/14/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/08/2023

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 02/02/2023

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 02/01/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 02/01/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 02/01/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 01/31/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 01/31/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 01/27/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 01/27/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 01/13/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 01/13/2023

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 01/12/2023

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 01/12/2023

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/05/2023

New York City REIT, Inc. (NYC) - 3

  • SEC Filings
  • 12/30/2022

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 12/29/2022

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 12/29/2022

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/29/2022

New York City REIT, Inc. (NYC) - AW

  • SEC Filings
  • 12/23/2022

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/21/2022

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/19/2022

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/16/2022

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/07/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 12/02/2022

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 12/01/2022

New York City REIT, Inc. (NYC) - 497J

  • SEC Filings
  • 12/01/2022

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 12/01/2022

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 11/25/2022

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 11/21/2022

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 11/21/2022

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 11/18/2022

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 11/16/2022

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 11/16/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 11/02/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 10/04/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 09/06/2022

New York City REIT, Inc. (NYC) - 497K

  • SEC Filings
  • 09/01/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 08/03/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 07/13/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 07/06/2022

New York City REIT, Inc. (NYC) - 497

  • SEC Filings
  • 06/13/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 06/03/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 05/13/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 05/11/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 05/06/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 05/04/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 05/02/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/29/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/27/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/25/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/22/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/20/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/15/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/13/2022

New York City REIT, Inc. (NYC) - 3

  • SEC Filings
  • 04/13/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 04/01/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/02/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/04/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/26/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/24/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/19/2022

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 05/21/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/30/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/26/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/24/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/22/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/18/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/16/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/12/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/10/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/08/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/04/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 03/02/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/26/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/24/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/22/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/18/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/16/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/11/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/09/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/05/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/03/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 02/01/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/28/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/26/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/22/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/20/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/15/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/13/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/11/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/07/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 01/05/2021

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 10/02/2020

New York City REIT, Inc. (NYC) - S-3

  • SEC Filings
  • 10/01/2020

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 08/31/2020

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 08/25/2020

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 08/20/2020

New York City REIT, Inc. (NYC) - S-8

  • SEC Filings
  • 08/19/2020

New York City REIT, Inc. (NYC) - S-3

  • SEC Filings
  • 08/19/2020

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 08/19/2020

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 08/18/2020

New York City REIT, Inc. (NYC) - CERT

  • SEC Filings
  • 08/14/2020

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 05/22/2020

New York City REIT, Inc. (NYC) - 3

  • SEC Filings
  • 09/19/2019

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 06/05/2019

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 06/22/2018

New York City REIT, Inc. (NYC) - 3

  • SEC Filings
  • 11/15/2017

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 10/06/2017

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 08/01/2016

New York City REIT, Inc. (NYC) - 3

  • SEC Filings
  • 08/01/2016

New York City REIT, Inc. (NYC) - 3

  • SEC Filings
  • 12/04/2015

New York City REIT, Inc. (NYC) - 4

  • SEC Filings
  • 07/14/2015

New York City REIT, Inc. (NYC) - 3

  • SEC Filings
  • 07/07/2015

New York City REIT, Inc. (NYC) - 3

  • SEC Filings
  • 07/02/2015

New York City REIT, Inc. (NYC) - S-3D

  • SEC Filings
  • 05/22/2015

New York City REIT, Inc. (NYC) - 3

  • SEC Filings
  • 03/04/2015

New York City REIT, Inc. (NYC) - S-11

  • SEC Filings
  • 02/26/2014

New York City REIT, Inc. (NYC) - DRS

  • SEC Filings
  • 01/16/2014
Press Releases
StockPrice Release
More Headlines
News

American Strategic Investment Co (NYC) Q3 2024 Earnings Call Transcript

  • American Strategic Investment Co (NYSE:NYC ) Q3 2024 Results Conference Call November 12, 2024 11:00 AM ET Company Participants Curtis Parker - Senior Vice President Michael Anderson - Chief Executive Officer Mike LeSanto - Chief Financial Officer Conference Call Participants Bryan Myers - B. Riley Securities Operator Good morning, and welcome to the American Strategic Investment Company Third Quarter Earnings Call.
  • 11/12/2024

American Strategic Investment Co. (NYC) Reports Q3 Loss, Lags Revenue Estimates

  • American Strategic Investment Co. (NYC) came out with a quarterly loss of $2.62 per share in line with the Zacks Consensus Estimate. This compares to loss of $4.10 per share a year ago.
  • 11/12/2024

American Strategic Investment Co. Announces Third Quarter 2024 Results

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”), a company that owns a portfolio of commercial real estate located within the five boroughs of New York City, announced today its financial and operating results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Revenue was $15.4 million compared to $16.0 million for the same quarter in 2023 Net loss attributable to common stockholders was $34.5 million, compared to $9.
  • 11/12/2024

American Strategic Investment Co. Announces Release Date for Third Quarter Results

  • NEW YORK--(BUSINESS WIRE)--AMERICAN STRATEGIC INVESTMENT CO. ANNOUNCES RELEASE DATE FOR THIRD QUARTER RESULTS.
  • 10/25/2024

American Strategic Investment Co. (NYC) Q2 2024 Earnings Call Transcript

  • American Strategic Investment Co. (NYSE:NYC ) Q2 2024 Earnings Conference Call August 9, 2024 11:00 AM ET Company Participants Curtis Parker - Senior Vice President Michael Anderson - Chief Executive Officer Mike LeSanto - Chief Financial Officer Conference Call Participants Bryan Myers - B. Riley Securities Operator Good morning and welcome to the American Strategic Investment Company's Second Quarter Earnings call.
  • 08/10/2024

American Strategic Investment Co. (NYC) Reports Q2 Loss, Lags Revenue Estimates

  • American Strategic Investment Co. (NYC) came out with a quarterly loss of $2.84 per share versus the Zacks Consensus Estimate of a loss of $2.99. This compares to loss of $4.77 per share a year ago.
  • 08/09/2024

Verizon announces early results of its private exchange offers for 10 series of notes and extension of early participation date

  • NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Verizon Communications Inc. (“Verizon”) (NYSE, NASDAQ: VZ) today announced (i) the early participation results, as of 5:00 p.m. (New York City time) on August 2, 2024 (the “Original Early Participation Date”), of its previously announced private offers to exchange the 10 outstanding series of notes listed in the table below and maturing from 2025 through 2028 (collectively, the “Old Notes”), in each case, for newly issued notes of Verizon due 2035 (the “New Notes”) (the “Exchange Offers”), on the terms and subject to the conditions set forth in an offering memorandum dated July 22, 2024 (the “Offering Memorandum”), as amended by Verizon's press release dated July 30, 2024 and (ii) that, with respect to the Exchange Offers, the date and time by which Eligible Holders (as defined below) must validly tender their Old Notes to receive the applicable Total Exchange Price (as defined in the Offering Memorandum), which includes the Early Participation Payment (as defined in the Offering Memorandum), has been extended to 5:00 p.m. (New York City time) on August 19, 2024 (such date and time with respect to an Exchange Offer, the “Extended Early Participation Date”). Accordingly, the Extended Early Participation Date will occur at the same time the Exchange Offers are scheduled to expire. Except as described in this press release, the terms and conditions of the Exchange Offers remain unchanged. The Offering Memorandum and the accompanying eligibility letter for the Exchange Offers constitute the “Exchange Offer Documents”.
  • 08/05/2024

American Strategic Investment Co. Announces Release Date for Second Quarter Results

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today it will release its financial results as of, and for the second quarter ended June 30, 2024, on Friday, August 9, 2024, before the New York Stock Exchange open. The Company will also host a webcast and conference call the same day at 11:00 a.m. ET to review results and provide commentary on business performance. A question-and-answer session will follow the prepared remarks. Dial-i.
  • 07/26/2024

BELLEVUE CAPITAL PARTNERS, LLC ANNOUNCES FINAL RESULTS OF TENDER OFFER FOR SHARES OF AMERICAN STRATEGIC INVESTMENT CORP.

  • NEW YORK , July 16, 2024 /PRNewswire/ -- Bellevue Capital Partners, LLC ("Bellevue") announced today the final results of its tender offer to purchase for cash up to 125,000 shares of American Strategic Investment Co. (NYSE: NYC) ("ASIC") common stock at a price of $11.00 per share (the "Tender Offer"), which expired at 5:00 p.m., New York City time, on July 15, 2024.
  • 07/16/2024

BELLEVUE CAPITAL PARTNERS, LLC INCREASES THE PURCHASE PRICE FOR ITS PREVIOUSLY ANNOUNCED TENDER OFFER FOR SHARES OF AMERICAN STRATEGIC INVESTMENT CORP.

  • $11.00 Offer Represents $0.75 Per Share Increase in Offer Price to May 7, 2024 Tender Offer NEW YORK , June 26, 2024 /PRNewswire/ -- Bellevue Capital Partners, LLC ("Bellevue") announced today that it has increased the purchase price of its previously announced tender offer to purchase up to 125,000 shares of American Strategic Investment Co. (NYSE: NYC) ("ASIC") common stock from the previous purchase price of $10.25 to an increased purchase price of $11.00 per share (the "Tender Offer"). The Tender Offer will close on July 5, 2024.
  • 06/26/2024

American Strategic Investment Co. Enters Into Letter of Intent to Sell 9 Times Square for $63.5 Million

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today that it has agreed to a term sheet to sell its 9 Times Square Midtown Manhattan property (“9 Times Square”) for $63.5 million. It is expected that the closing of the transaction will occur within 120 days of the execution of a definitive purchase and sale agreement between the parties. The Company previously announced that it had secured an amendment of the loan on 9 Times Square,.
  • 06/26/2024

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger and Tender Offer Expiring on July 5, 2024, for American Strategic Investment Company - NYC

  • NEW YORK , June 4, 2024 /PRNewswire/ --  Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating American Strategic Investment Company (NYSE: NYC), relating to a tender offer from Bellevue Capital Partners, LLC.
  • 06/04/2024

BELLEVUE CAPITAL PARTNERS, LLC INCREASES THE PURCHASE PRICE FOR ITS PREVIOUSLY ANNOUNCED TENDER OFFER FOR SHARES OF AMERICAN STRATEGIC INVESTMENT CORP.

  • $10.25 Offer Represents $1.00 Per Share Increase in Offer Price to May 7, 2024 Tender Offer  NEW YORK , May 23, 2024 /PRNewswire/ -- Bellevue Capital Partners, LLC ("Bellevue") announced today that it has increased the purchase price of its previously announced tender offer to purchase up to 125,000 shares of American Strategic Investment Co. (NYSE: NYC) ("ASIC") common stock from the previous purchase price of $9.25 to an increased purchase price of $10.25 per share (the "Tender Offer"). The Tender Offer will close on July 5, 2024.
  • 05/23/2024

American Strategic Investment Co. Announces Response to Bellevue Capital Partners, LLC Tender Offer

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today that it has filed with the Securities and Exchange Commission (“SEC”) a Solicitation/Recommendation Statement on Schedule 14D-9 and Letter to Stockholders dated May 21, 2024, regarding the tender offer commenced by Bellevue Capital Partners, LLC (“Bellevue”) on May 7, 2024, to purchase up to 125,000 shares of the Company's Class A common stock at a price of $9.25 per share (the “Te.
  • 05/21/2024

loanDepot Commences Exchange Offer and Consent Solicitation for 6.500% Senior Notes due 2025

  • IRVINE, Calif.--(BUSINESS WIRE)--loanDepot, Inc. (NYSE: LDI) (“loanDepot”) announced today that its subsidiary, LD Holdings Group LLC (the “Issuer”), has commenced an offer (the “Exchange Offer”) to certain Eligible Holders (as defined below) to exchange any and all of its outstanding 6.500% Senior Notes due 2025 (the “Old Notes”) for newly issued 8.250% Senior Secured Notes due 2027 (the “New Notes”), and a related consent solicitation upon the terms and conditions set forth in the confidential Offering Memorandum and Consent Solicitation Statement dated May 20, 2024 (the “Offering Memorandum and Consent Solicitation Statement”). The following table below summarizes the principal economic terms of the Exchange Offer: Exchange Consideration per $1,000 Principal Amount of Old Notes Tendered Principal Amount of Total Consideration for Old Notes Tendered at or Prior to the Early Tender Time Tender Consideration for Old Notes Tendered After the Early Tender Time CUSIP Numbers 2025 Notes Outstanding New Notes (principal amount) Cash New Notes (principal amount) Cash 521088AA2 (144A) U5140UAA8 (Reg S) $497,750,000 $850 $250 $850 $200 Eligible Holders that validly tender and do not validly withdraw their Old Notes in the Exchange Offer at or prior to 5:00 p.m., New York City time, on June 3, 2024, unless extended (such date and time, as they may be extended, the “Early Tender Time”), will be eligible to receive $850 principal amount of New Notes and $250 in cash for each $1,000 principal amount of Old Notes tendered (the “Total Consideration”). Such amount includes an “Early Tender Premium” of $50 in cash per $1,000 principal amount of Old Notes tendered. Eligible Holders tendering Old Notes after the Early Tender Time and at or prior to 5:00 p.m., New York City time, on June 18, 2024, unless extended (such date and time, as may be extended, the “Expiration Time”), will only be eligible to receive $850 principal amount of New Notes and $200 in cash for each $1,000 principal amount of Old Notes tendered (the “Tender Consideration”). The New Notes will pay interest at a rate of 8.250% and mature November 1, 2027. The New Notes will be guaranteed by the subsidiaries of the Issuer that are guarantors of the Old Notes and the Issuer’s outstanding 6.125% Senior Notes due 2028 and will be secured, subject to permitted liens, by a first-priority security interest on (1) all of the membership interests of mello Credit Strategies LLC, a direct subsidiary of the Issuer, (2) certain unencumbered non-agency mortgage servicing rights held by loanDepot.com, LLC, a guarantor of the New Notes, with a fair value of up to $60.0 million and (3) $100.6 million aggregate principal amount of 2028 Senior Notes that were previously repurchased by the Issuer and to be held by Artemis Management LLC, a guarantor of the New Notes (collectively, the “Collateral”) as described in the Offering Memorandum and Consent Solicitation Statement. The covenants for the New Notes will be similar to the covenants for the Old Notes with customary modifications for an issuance of secured notes, including prohibiting the Issuer from incurring (a) additional debt secured by the Collateral and (b) capital markets indebtedness secured by non-Collateral. In conjunction with the Exchange Offer, the Issuer is soliciting consents (the “Consent Solicitation”) to eliminate substantially all restrictive covenants and certain of the default provisions (the “Proposed Amendments”) in the indenture governing the Old Notes. Holders who tender their Old Notes in the Exchange Offer will be deemed to have submitted consents pursuant to the Consent Solicitation. The consummation of the Exchange Offer is not subject to, or conditioned upon, the receipt of the requisite consents or to any minimum amount of Old Notes being tendered for exchange. The consummation of the Exchange Offer and Consent Solicitation is subject to the satisfaction or waiver of certain conditions set forth in the confidential Offering Memorandum and Consent Solicitation Statement. Tendered Old Notes may be validly withdrawn at any time prior to 5:00 p.m., New York City time, on June 3, 2024, but not thereafter. Settlement will occur promptly after the Expiration Time and is currently expected to occur on or about June 24, 2024 (the “Settlement Date”). Eligible Holders that validly tender Old Notes at or prior to the Expiration Time will also be eligible to receive cash for accrued and unpaid interest on the exchanged Old Notes from the last interest payment date prior to, but not including, the Settlement Date. Interest on the New Notes will accrue from the Settlement Date. Documents relating to the Exchange Offer and Consent Solicitation will only be distributed to Eligible Holders of the Old Notes who properly complete and return an eligibility form confirming that they are either a “qualified institutional buyer” as defined in Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), or a non-U.S. person in compliance with Regulation S under the Securities Act (such holders, “Eligible Holders”). The complete terms and conditions of the Exchange Offer and Consent Solicitation are described in the Offering Memorandum and Consent Solicitation Statement, copies of which may be obtained by contacting Global Bondholder Services Corporation, the information and exchange agent in connection with the Exchange Offer and Consent Solicitation, at (855) 654-2014 (U.S. toll-free) or (212) 430-3774 (banks and brokers). The eligibility form is available electronically at: https://gbsc-usa.com/eligibility/loandepot. This press release is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell the New Notes. The Exchange Offer and Consent Solicitation is only being made pursuant to the Offering Memorandum and Consent Solicitation Statement. The Exchange Offer is not being made to holders of Old Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. The New Notes will not be registered under the Securities Act, or any other applicable securities laws and, unless so registered, the New Notes may not be offered, sold, pledged or otherwise transferred within the United States or to or for the account of any U.S. person, except pursuant to an exemption from the registration requirements thereof. Accordingly, the New Notes are being offered and issued only (i) to persons reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the Securities Act) and (ii) to non-“U.S. persons” who are outside the United States (as defined in Regulation S under the Securities Act). Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements that are based on management’s beliefs and assumptions and on information currently available to management. Forward-looking statements include statements that are not historical facts and can be identified by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “will,” “would” or similar expressions and the negatives of those terms. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as the satisfaction of the conditions described in the confidential Offering Memorandum and Consent Solicitation Statement, that may cause loanDepot’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Given these uncertainties, you should not place undue reliance on forward-looking statements. Also, forward-looking statements represent management’s beliefs and assumptions only as of the date of this press release. You should read this press release with the understanding that loanDepot’s actual future results may be materially different from what loanDepot expects. Important factors that could cause actual results to differ materially from loanDepot’s expectations are included in the section entitled “Risk Factors” set forth in the confidential Offering Memorandum and Consent Solicitation Statement and under the caption “Risk Factors” included in loanDepot’s Annual Report on Form 10-K for the year ended December 31, 2023, incorporated by reference into the Offering Memorandum. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in loanDepot’s filings. loanDepot expressly disclaims any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise, except as required by applicable law. About loanDepot loanDepot (NYSE: LDI) is a leading provider of lending solutions that make the American dream of homeownership more accessible and achievable for all, especially the increasingly diverse communities of first-time homebuyers, through a broad suite of lending and real estate services that simplify one of life’s most complex transactions. Since its launch in 2010, the company has been recognized as an innovator, using its industry-leading technology to deliver a superior customer experience. Our digital-first approach makes it easier, faster and less stressful to purchase or refinance a home. Today, as one of the largest non-bank lenders in the country, loanDepot and its mellohome operating unit offer an integrated platform of lending, loan servicing, real estate and home services that support customers along their entire homeownership journey. Headquartered in Southern California and with hundreds of local market offices nationwide, loanDepot’s passionate team is dedicated to making a positive difference in the lives of their customers every day.
  • 05/20/2024

One of 2024's Most Heartwarming and Feel-Good Stories Is The Rider by Author Jeffrey Miller

  • One of 2024's Most Heartwarming and Feel-Good Stories Is The Rider by Author Jeffrey Miller May 20, 2024 9:05 AM EDT | Source: Dabb Media, LLC San Francisco, California--(Newsfile Corp. - May 20, 2024) - Author Jeffrey Miller has announced the release of his debut audiobook, The Rider: Help from an Unexpected Source. This thought-provoking story highlights the power of hope, opportunity, and friendship in unexpected places.Book cover of The RiderThe Rider follows the life of a newly homeless man living in Manhattan. After taking refuge in the subway, he encounters one of New York City's many rats. This rat, however, has both extraordinary intelligence and a deep sense of compassion. Before long, the rat not only becomes his friend and protector but also saves him from a life on the streets. The rat, something hardly noticed in society, serves to show that goodness and wisdom can be found in even the smallest of creatures. Both young adult and adult audiences will appreciate this heartwarming tale of redemption and kindness. Myriam Berger's emotional narration of Miller's evocative storytelling makes this standout audiobook perfect for those who love stories but may be reluctant to read.The Rider will especially resonate with audiences that enjoy a wholesome, feel-good story. While the story is about a rat, an often overlooked, despised animal, making an outsized difference, the underlying message can be applied to overlooked people, overlooked situations, and more. As the author would put it, 'For a giver, one does not need to be great to do good. For a receiver, be open as help may come from unexpected sources. Let us not judge others too quickly.'The Rider: Help from an Unexpected Source is available for purchase on Audible.com, Google Play, or wherever books are sold.Jeff Miller is an author and software engineer. Throughout his life, he has lived in both Manhattan and Silicon Valley. Source:Charlotte Simmonsinfo@dabb.mediaDabb MediaTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/209647 SOURCE: Dabb Media, LLC Learn more about Bill C-18 and how it will affect Canadian users when viewing news online.
  • 05/20/2024

Explore California, The Ultimate Playground: Memorial Day, Summer 2024

  • CALIFORNIA — If you’re planning to explore California for the three-day Memorial Day weekend, knowing when to avoid the busiest times on major routes can make the difference between a stress-free holiday or one the kids will never let you forget. Some 43.8 million Americans are expected to travel at least 50 miles from home to celebrate Memorial Day in 2024. That's a 4 percent increase from last year, AAA said in its annual Memorial Day travel forecast. Travel this year could approach the record set in 2005 when 44 million people took Memorial Day trips. Many California residents plan to set out and enjoy all that their state has to offer over the three-day weekend. Memorial Day, the unofficial start to summer, has always been a big road trip holiday. About 38.4 million people plan to take off in their cars, the highest number for the holiday since AAA began tracking Memorial Day travel in 2000. Ahead of Memorial Day in California, regular gasoline was selling for an average statewide price of $5.33 a gallon. Pump prices always creep higher as the summer driving season gets underway, and wars in Ukraine and the Middle East could roil the oil market, AAA cautioned. Be prepared. Heading to some of California's most favored destinations might require a tank or two of gas to get there. "The Golden State is massive," according to Visit California. The third largest state in the nation, it comprises more square miles than many countries. "To see a good chunk of California in one trip, you need to strategize. Setting from Southern California to Northern California can take 15 hours by car, the same distance from New York City to Jacksonville, Florida." For some quick weekend trips across the state, flying may be your best option. Airports are expected to be busier than last year, too, with about 3.51 million people flying to their Memorial Day destinations, 4.8 percent more than last year and 9 percent more than pre-pandemic 2019. AAA said crowds could rival the post-9/11 recovery in 2005, when 3.64 million people flew. “We haven’t seen Memorial Day weekend travel numbers like these in almost 20 years.” Paula Twidale, a senior vice president at AAA Travel, said in a news release. “We’re projecting an additional 1 million travelers this holiday weekend compared to 2019, which not only means we’re exceeding pre-pandemic levels but also signals a very busy summer travel season ahead.” Where are the best destinations in the Golden State? According to Wallet Hub, the Los Angeles, Long Beach, and Anaheim areas are among the most visited in California over the summer months, but Californians can see much more outside of the metro areas. Travel Times To Avoid AAA’s transportation data partner, INRIX, says drivers who are leaving on Thursday and Friday should get on the road early to avoid peak commute time. Travelers returning from their getaways on Sunday and Monday should avoid the peak travel afternoon hours. “Travel times are expected to be 90 percent longer than normal,” Bob Pishue, a transportation analyst at INRIX, said in a news release. He advised road trippers to remain up to date on traffic apps, 511 services and local news stations to avoid sitting in traffic any longer than necessary. These are the best and worst times to travel by car (all times local): Thursday, May 23 Friday, May 24 Saturday, May 25 Sunday, May 26 Monday, May 27 Peak Congestion Times: Here are the peak congestion times for busy metropolitan routes, the estimated travel time and the increase in traffic due to the holiday: Other Means Of Travel Rebound While most people are either driving or flying to their Memorial Day destinations, about 1.9 million people will take trains, buses and cruises, an increase of 5.6 percent from last year, AAA said. “This category took the biggest hit during the pandemic with fewer people taking public transportation or not cruising at all,” Twidale said. “Now — five years later — we’re back to 2019 numbers. Travel demand has been soaring, and long holiday weekends create the perfect windows for getaways.” Related:
  • 05/20/2024

Saluda Grade Awarded both RMBS Issuer of the Year and RMBS Deal of the Year at the 2024 GlobalCapital US Securitization Awards

  • NEW YORK--(BUSINESS WIRE)--Saluda Grade, an alternative asset management platform focused on emerging asset classes within the U.S. real estate sector, is thrilled to announce being awarded both RMBS Issuer of the Year and RMBS Deal of the Year at the 2024 GlobalCapital US Securitization Awards held Thursday, May 16th in New York City. Saluda Grade was awarded Residential Mortgage-Backed Securities (RMBS) Issuer of the Year over industry giants, including Freddie Mac and Fannie Mae, cementing its leadership position in the RMBS securitization market. The RMBS Deal of the Year, UNLOK 2023-1, was a groundbreaking close of the industry's first rated securitization backed by Home Equity Agreements (HEAs). This securitization has helped solidify HEAs as a well-structured consumer finance product valuable to both homeowners and investors. The GlobalCapital US Securitization Awards feature leading banks, issuers, deals, investors, and service providers within the industry. The awards showcase those firms recognized as leading sponsors within their peer group, with winners selected through an industry vote. "These wins are a testament to the dedication of our team and our continued effort to deliver differentiated investment opportunities to the securitization markets and our institutional investor partnerships," said Saluda Grade Founder & CEO Ryan Craft. Saluda Grade had a solid finish to 2023, closing five deals (~$1.6B in total) in Q4. Included among these deals was the inaugural securitization of Home Improvement Loans originated by Momnt and the largest ever construction loan securitization, which was comprised of loans originated by Builders Capital. The momentum has continued in 2024 with Saluda Grade closing an additional five deals (~1.3B in total) year to date. Overall, Saluda Grade has completed 33 securitizations (~$7.8B in total) since its inception, establishing itself as a market leader across alternative mortgage and residential adjacent assets. About Saluda Grade Saluda Grade is an alternative asset manager focused on opportunities in asset backed finance, real estate debt and equity, and hard asset sectors. Headquartered in New York City, the Firm was founded in 2019. See saludagrade.com for additional information. Disclaimer: This press release is for informational purposes only and is neither an offer to sell nor the solicitation of an offer to any for any other securities, and shall not constitute an offer, solicitation or sale. Any offers will be made only by means of a private offering memorandum. The RMBS Issuer of the Year award for 2023 was open to anyone active in the securitization market and recipients of the award were based on organizations which had been involved in the most innovative or challenging transactions, the quality of execution and structuring; investment, growth, and progression in the business, or those who stood out for the breadth and depth of their securitization franchises. There were 7 finalists considered for this award. Saluda Grade did not pay a fee to be considered for this award. The RMBS Deal of the Year award for 2023 was open to all US RMBS deals issued in 2023. Deals were considered based on their impact on the market, how well they timed and read the market and their reach among investors, as well as innovation. There were 5 finalists considered for this award. Saluda Grade did not pay a fee to be considered for this award.
  • 05/20/2024

The Moinian Group Hosts Inaugural ‘Moinian Mile’ Event in Manhattan

  • NEW YORK--(BUSINESS WIRE)--The Moinian Group, one of the world’s largest privately held real estate investment companies, hosted the first of its kind, Moinian Mile, an exclusive, invite-only, two day event for New York City’s top producing commercial brokers across four properties within the firm’s Midtown south office portfolio, 60 Madison Avenue, 245 Fifth Avenue, 72 Madison Avenue and 450-460 Park Avenue South. “We are thrilled with the success of the first-ever Moinian Mile. We successfully brought over 230 of New York City’s most prominent brokers across four of our most in-demand properties and offered unparalleled grand prize offerings,” said Nick Berger, Director of Commercial Leasing at The Moinian Group. “As we continue experiencing upticks in leasing velocity across our commercial portfolio, we look forward to hosting more events and continuing to raise the bar in broker engagement.” The event included inside access and tours of all participating properties and each location was activated with golf simulators, outdoor terrace games, ample food and beverage offerings and the opportunity to win three incomparable grand prizes, a weekend trip for up to ten people by private jet to Miami, courtside tickets to a 2024-2025 season New York Knicks game and a Blade helicopter ride from your choice point of origin to John F. Kennedy International Airport. Prominent real estate members in attendance included EN Cutler, Managing Director at Newmark, Noel Flagg, Managing Director at Newmark, Andrew Ross, Managing Director at Cushman & Wakefield, Randy Abend, Managing Director at JLL and Rob Gallucci, Executive Vice President at Colliers. Winners of the grand prizes were Kyle Zarba, Associate at CBRE (Knicks tickets), Matthew Becker, Assistant Director at Savills (Blade helicopter trip) and Paul Formichelli, Managing Director at JLL (private jet to Miami). The Moinian Group has seen a robust and continued uptick in leasing velocity across their portfolio of premier commercial assets, with the recent signing of Paris Saint-Germain, the Paris-based professional football club bringing the retail component of 535 Fifth Avenue to 100 percent occupancy. Across The Moinian Group’s Flatiron portfolio, the firm last week announced it inked five new leases across five properties with Kids at Work, LineLeap, Yinova Management Company, PlayPlay and Tej Beauty Enterprises, Inc. About The Moinian Group Founded by Joseph Moinian, The Moinian Group today owns and operates a diversified portfolio of assets across the United States and is among the only national real estate entities to develop, own and operate properties across every asset category, including office, hotel, retail, and residential. The Moinian Group's holdings include high-profile assets in America's leading cities, including New York, Dallas, Miami and Los Angeles. For the past three decades, The Moinian Group has been a pioneer in the development of emerging areas of New York City such as Downtown and West Side of Manhattan, developing commercial, residential and mixed-use projects that combine luxury living, modern office space and high-quality retail. The Moinian Group maintains a reputation for developing state-of-the-art, aesthetically distinguished properties as the firm continues to strive for excellence. More information on the Moinian Group and its portfolio can be found at www.moinian.com.
  • 05/20/2024

Karmanos Welcomes Wasif Saif, M.D., to Lead Phase 1 Clinical Trials

  • Internationally known clinical and translational researcher also co-leads the GI oncology team DETROIT, May 20, 2024 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute welcomes Wasif Saif, M.D., MBBS, as the new leader of the Phase 1 Clinical Trials Multidisciplinary Team and co-leader of the Gastrointestinal (GI) and Neuroendocrine Oncology Multidisciplinary Team (MDT). Dr. Saif is a world-renowned hematologist and oncologist specializing in GI cancers, experimental therapeutics and pharmacogenetics. He joined Karmanos on March 1, 2024. "Karmanos Cancer Institute is a trailblazer in cancer research and has been a major contributor to significant strides in new drug and therapy development," said Dr. Saif. "I am most excited about continuing translational research at this NCI-Designated Comprehensive Cancer Center with access to a diverse cancer population. This cancer center's rich data from clinical trials, studies, and investigations largely shapes the understanding of cancer and treatment for multiple populations. The avenues the physicians, scientists, and researchers have open to them are endless, and I am honored to be part of this significant work in Detroit." Dr. Saif has an extensive background in translational research and developing and managing clinical trials. As the Phase 1 Clinical Trials MDT leader, he will lead a team of physician co-investigators, non-physician providers, clinical personnel, and Clinical Trials Office staff to oversee Phase 1 solid tumor investigations. Karmanos' Phase 1 team oversees over 70 clinical trials at various stages of the protocol lifecycle. Members of this MDT include medical oncologists specializing in many different cancers, who research, study, and develop therapies, bringing them from lab to bedside. Having a Phase 1 team in Detroit gives cancer patients access to promising new treatments not offered elsewhere. Dr. Saif will also work alongside Najeeb Al Hallak, M.D., MS, medical oncologist, in leading the GI and Neuroendocrine Oncology MDT, a team made up of cardiothoracic surgeons, endocrinologists, gastroenterologists, hematologists, medical oncologists, pathologists, radiologists, radiation oncologists, and surgical oncologists that dedicate their research and treatment to GI and neuroendocrine cancers. He specializes in treating anal, biliary, colon, carcinoid, esophagus, GIST, liver, pancreas, rectum, and stomach cancers. His research interests include anticancer drug development with an emphasis on analysis of pharmacokinetics and pharmacodynamics, biomarker discovery, pharmacogenetics, epidemiology and disparity studies in GI cancers, and developing complementary and alternative medicines to treat cancer. "Dr. Saif's philosophy and leadership in novel therapeutics fits our vision of continuing to grow our Phase 1 Clinical Trials Program at Karmanos. His research interests in GI cancers will complement our GI team. I am confident we will see more breakthrough discoveries from these MDTs with Dr. Saif's leadership and vision," said Boris Pasche, M.D. Ph.D., FACP, president and CEO at Karmanos. In addition to his leadership roles, Dr. Saif sees patients at Karmanos Cancer Center in Detroit. He is also a professor in the Department of Oncology at Wayne State University School of Medicine. Before joining Karmanos, Dr. Saif served on the faculty at the University of Alabama at Birmingham, Yale University School of Medicine in New Haven, Connecticut, Columbia University in New York City, and Tufts University School of Medicine in Boston, Massachusetts. He has served as the leader of the GI oncology division at Yale, Columbia, and Tufts and as the program leader in experimental therapeutics at Tufts. He has also served in executive roles at Northwell Health in New Hyde Park, New York and Orlando Health. Dr. Saif is a member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), European Society of Medical Oncology (ESMO), Carcinoid Foundation, and American Society of Pharmacology and Experimental Therapeutics (ASPET). He has served as the principal investigator on over 75 clinical trials and has published over 650 scientific papers in addition to textbook chapters, abstracts, and proceedings of meetings. Dr. Saif earned his medical degree from King Edward Medical College in Lahore, Pakistan, and completed his internal medicine residency at the University of Connecticut School of Medicine in Farmington, Connecticut. He completed medical oncology and hematology fellowships at the National Cancer Institute, National Heart, Lung and Blood Institute, National Institutes of Health, and National Naval Medical Center in Bethesda, Maryland. View Dr. Saif's physician profile here. To learn more about Phase 1 Clinical Trials or to request an appointment, visit karmanos.org or call 1-800-KARMANOS. About the Barbara Ann Karmanos Cancer InstituteKarmanos Cancer Institute is a leader in transformative cancer care, research and education through courage, commitment and compassion. The Karmanos vision is a world free of cancer. As part of McLaren Health Care, Karmanos is the largest provider of cancer care and research in Michigan. For more than 75 years, the administrative and research headquarters, along with the premier specialty cancer hospital, have been located in downtown Detroit. With 16 network sites, Karmanos delivers world-renowned care and access to clinical trials throughout Michigan and northern Ohio. The National Cancer Institute recognizes Karmanos as one of the best cancer centers in the nation with a comprehensive cancer center designation. Its academic partnership with the Wayne State University School of Medicine provides the framework for cancer research and education – defining new standards of care and improving survivorship. For more information, call 1-800-KARMANOS (800-527-6266) or visit www.karmanos.org.
  • 05/20/2024

ICON plc to hold Investor Day Meeting on May 30, 2024

  • DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will hold an Investor Day which will take place on Thursday, May 30, 2024 in New York City, starting at 10am ET. The event will include presentations from members of ICON’s executive team, and access to a live webcast will be made available in on the Investor section of our website. It is expected that the presentations, followed by a question and answer session, will conclude at approximately 1pm ET. Any changes to these events and links to the live webcast will be posted on the Investor section of our website under “Events”. About ICON plc ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,150 employees in 102 locations in 54 countries as at March 31, 2024. For further information about ICON, visit: www.iconplc.com. This press release contains forward-looking statements, including statements about our financial guidance. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov. ICON/ICLR-G
  • 05/20/2024

Terreno Realty Co. (NYSE:TRNO) Shares Sold by Amalgamated Bank

  • Amalgamated Bank reduced its stake in shares of Terreno Realty Co. (NYSE:TRNO – Free Report) by 10.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,213 shares of the real estate investment trust’s stock after selling 822 shares during the quarter. Amalgamated Bank’s holdings in Terreno Realty were worth $452,000 as of its most recent filing with the Securities and Exchange Commission. Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. SRS Capital Advisors Inc. grew its position in Terreno Realty by 337.2% during the fourth quarter. SRS Capital Advisors Inc. now owns 529 shares of the real estate investment trust’s stock worth $33,000 after buying an additional 408 shares during the period. Exchange Traded Concepts LLC acquired a new position in Terreno Realty during the fourth quarter worth about $35,000. Blue Trust Inc. grew its position in Terreno Realty by 84.2% during the fourth quarter. Blue Trust Inc. now owns 989 shares of the real estate investment trust’s stock worth $62,000 after buying an additional 452 shares during the period. Dfpg Investments LLC acquired a new position in Terreno Realty during the fourth quarter worth about $200,000. Finally, Covestor Ltd grew its position in Terreno Realty by 16.9% during the third quarter. Covestor Ltd now owns 3,561 shares of the real estate investment trust’s stock worth $202,000 after buying an additional 514 shares during the period. Terreno Realty Stock Performance Shares of TRNO opened at $58.10 on Monday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 10.17 and a current ratio of 10.17. The company has a market capitalization of $5.62 billion, a price-to-earnings ratio of 30.26, a PEG ratio of 2.84 and a beta of 0.85. The company’s 50 day simple moving average is $59.61 and its 200 day simple moving average is $60.22. Terreno Realty Co. has a 1 year low of $50.42 and a 1 year high of $66.63. Terreno Realty Dividend Announcement The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $1.80 annualized dividend and a dividend yield of 3.10%. Terreno Realty’s dividend payout ratio is presently 93.75%. Analysts Set New Price Targets Several research firms have recently commented on TRNO. Scotiabank lowered their price target on shares of Terreno Realty from $66.00 to $59.00 and set a “sector perform” rating on the stock in a research report on Thursday. Mizuho increased their price target on shares of Terreno Realty from $52.00 to $62.00 and gave the company a “neutral” rating in a research report on Tuesday, April 2nd. StockNews.com lowered shares of Terreno Realty from a “hold” rating to a “sell” rating in a research report on Wednesday, May 15th. Barclays began coverage on shares of Terreno Realty in a research report on Wednesday, March 27th. They issued an “overweight” rating and a $71.00 price target on the stock. Finally, JMP Securities reiterated a “market outperform” rating and issued a $65.00 price target on shares of Terreno Realty in a research report on Monday, May 13th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, Terreno Realty currently has an average rating of “Hold” and a consensus price target of $64.56. Check Out Our Latest Report on TRNO Terreno Realty Company Profile (Free Report) Terreno Realty Corporation (Terreno, and together with its subsidiaries, the Company) acquires, owns and operates industrial real estate in six major coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, DC All square feet, acres, occupancy and number of properties disclosed in these notes to the consolidated financial statements are unaudited. Read More Five stocks we like better than Terreno Realty How Investors Can Identify and Successfully Trade Gap-Down Stocks MarketBeat Week in Review – 5/13 – 5/17 What Are Dividend Achievers? An Introduction Take-Two Interactive Software Offers 2nd Chance for Investors What is a SEC Filing? Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook
  • 05/20/2024

PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share

  • BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces the opening of its proposed $100 million tender offer (the “Tender Offer”). Tender Offer Highlights The Tender Offer opens today 20 May 2024. Subject to the terms and conditions of the Tender Offer, the Company will purchase for cash a maximum of $100 million in value of ordinary shares of one pence each in the capital of the Company (“Ordinary Shares”) (including Ordinary Shares represented by the Company’s American Depositary Shares each representing 10 Ordinary Shares (“ADSs”)). The Tender Offer for the Company’s Ordinary Shares will close at 1:00 p.m. London time on Thursday 20 June 2024 (the “Ordinary Share Closing Date”), and the Tender Offer for the Company’s ADSs will close at 5:00 p.m. New York City time on Tuesday 18 June 2024 (the “ADS Closing Date”), unless the Tender Offer is extended. The Company is offering to purchase up to 33,500,000 Ordinary Shares (including Ordinary Shares represented by ADSs) representing approximately 12 percent of the Company’s issued ordinary share capital as at 16 May 2024 (being the latest practicable date before publication of this announcement (“Latest Practicable Date”)) at a fixed price of 250 pence per Ordinary Share (equivalent to £25.00 per ADS) (the “Tender Price”) up to a maximum aggregate amount of $100 million. The maximum amount of $100 million will be translated into a pounds sterling amount on the Ordinary Share Closing Date, and that pounds sterling amount shall determine the maximum number of shares to be accepted for payment in the Tender Offer. The Tender Price represents a premium of 25 percent to PureTech’s trailing volume weighted average price per Ordinary Share over the three days prior to 19 March 2024, the date of the Company’s initial announcement of the Tender Offer proposals and a premium of 12.6 percent to the closing price of 222 pence per Ordinary Share on the Latest Practicable Date. If the full $100 million is not returned through the Tender Offer, then, if there is sufficient surplus, the Company’s board of directors (“Board”) intends to return such surplus by way of a special dividend following completion of the Tender Offer, without interest, less any applicable withholding taxes and subject to market and industry conditions at the time and any relevant legal restrictions (the “Special Dividend”). Completion of the Tender Offer will be conditional, among other things, on shareholder approval at a general meeting of the Company to be held at 11:00 a.m. New York City time (4:00 p.m. London time) on 6 June 2024 at the Company’s offices at 6 Tide Street, Boston, Massachusetts, 02210, United States (the “General Meeting”). Full details of the Tender Offer are included in a circular to the Company’s Shareholders (the “Circular”) which will be mailed to Shareholders and ADS Holders today and available on a website set up by the Company for the purposes of the Tender Offer. The website is available at https://investors.puretechhealth.com/tender-offer. Copies of the Circular will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The Circular will also be included as an exhibit to the Schedule TO to be filed with the Securities and Exchange Commission and will be available for inspection at https://www.sec.gov. SHAREHOLDERS AND ADS HOLDERS ARE ADVISED TO CONSULT WITH THEIR PROFESSIONAL TAX ADVISORS IN CONNECTION WITH CERTAIN US FEDERAL WITHHOLDING TAX CONSIDERATIONS DESCRIBED IN FURTHER DETAIL BELOW (SEE “Certain US Federal Income Tax Considerations with Respect to the Tender Offer”). Structure of the Tender Offer The Tender Offer will be implemented on the basis of Jefferies International Limited (“Jefferies”) acquiring, as principal, the successfully tendered Ordinary Shares (including Ordinary Shares represented by ADSs) at the Tender Price. In turn, Jefferies has the right to require the Company to purchase such Ordinary Shares (including Ordinary Shares represented by ADSs) from it at the same Tender Price pursuant to an option agreement entered into between the Company and Jefferies (the “Option Agreement”). If Jefferies does not exercise its right to require the Company to purchase such Ordinary Shares (including Ordinary Shares represented by ADSs), the Company has the right to require Jefferies to sell such Ordinary Shares (including Ordinary Shares represented by ADSs) to it at the same price. The Company intends to cancel the Ordinary Shares (including Ordinary Shares represented by ADSs) purchased by it pursuant to the Tender Offer. Shareholders can decide whether they want to tender all, some or none of their Ordinary Shares or ADSs in the Tender Offer. If the aggregate value at the Tender Price of all validly tendered Ordinary Shares (including Ordinary Shares represented by ADSs) exceeds $100 million (based on the applicable exchange rate of US dollars to pounds sterling on the Ordinary Share Closing Date) or the number of validly tendered Ordinary Shares (including Ordinary Shares represented by ADSs) exceeds 33,500,000 Ordinary Shares, then not all of the Ordinary Shares (including Ordinary Shares represented by ADSs) validly tendered will be accepted and purchased. In these circumstances, tenders will be scaled down pro-rata to the total number of Ordinary Shares (including Ordinary Shares represented by ADSs) so tendered by that shareholder, such that the total cost of Ordinary Shares (including Ordinary Shares represented by ADSs) purchased pursuant to the Tender Offer does not exceed $100 million or the total number of validly tendered Ordinary Shares (including Ordinary Shares represented by ADSs) does not exceed 33,500,000 Ordinary Shares. Certain US Federal Income Tax Considerations with Respect to the Tender Offer Shareholders and ADS Holders should consult their professional tax advisors in connection with the Tender Offer. Shareholders and ADS Holders should note that, due to the circumstances of its formation and the application of Section 7874 of the United States Internal Revenue Code of 1986, as amended (“Code”), the Company is treated as a US domestic corporation for US federal income tax purposes. Accordingly, the Company is subject to US federal income tax as if it were a US corporation, and distributions made by the Company (including certain payments in respect of the Tender Offer that are treated as distributions for US federal income tax purposes) are generally treated as US-source dividends, as if the Company were incorporated in the US. As a result, both US Holders and Non-US Holders (each as defined in the Circular) may be subject to US federal income tax withholding on receipt of cash proceeds from any tendered Ordinary Shares or ADSs accepted in the Tender Offer and the Special Dividend (if any). The attention of Shareholders and ADS Holders is drawn to Part VI of the Circular, which provides a summary of certain material UK tax and US federal income tax consequences for Shareholders and ADS Holders of accepting the Tender Offer or receipt of the Special Dividend (if any). All Shareholders and ADS Holders should receive a Section 302 Certification. Copies of the Section 302 Certification, IRS Form W-9, and IRS Forms W-8, as well the IRS instructions with respect to such IRS Forms, are also available on the Microsite set up by the Company for the purposes of the Tender Offer. The Microsite is available at https://investors.puretechhealth.com/tender-offer. In consultation with their professional tax advisors regarding their individual circumstances, Shareholders and ADS Holders should complete the Section 302 Certification and an IRS Form W-9 or applicable IRS Form W-8, as applicable, in accordance with the instructions thereon. Shareholders and ADS Holders should return the properly completed Section 302 Certification and the IRS Form W-9 or applicable IRS Form W-8, as applicable, in accordance with the instructions set forth the Circular, the Tender Form, the Letter of Transmittal and the Section 302 Certification, as applicable. Part VI of the Circular also provides additional information to Shareholders and ADS Holders on the process for returning a Section 302 Certifications and an IRS Form W-9 or applicable IRS Forms W-8, as applicable. The appropriate IRS Form W-9 or Form W-8 should be returned whether or not a Shareholder plans to participate in the Tender Offer, if not previously provided. IRS Form W-9 and IRS Form W-8 will also be relevant in connection with the Special Dividend (if any). This information is not tax advice, and the Company cannot advise you with respect to taxes. Shareholders and ADS Holders should consult their professional tax advisors, in particular regarding their individual tax position and the exemptions or reductions of US withholding tax that may be available to them. For more information, Shareholders and ADS Holders should read the full text of this announcement of the Tender Offer, the Circular, the Tender Form, and the Letter of Transmittal. General Meeting Implementation of the Tender Offer is conditional upon, amongst other things, the approval of the shareholders of the resolution necessary to implement the Tender Offer (the “Resolution”). For this purpose, the Company is convening the General Meeting for 11 a.m. New York City time (4 p.m. London time) on 6 June 2024 to be held at 6 Tide Street, Boston, Massachusetts, 02210, United States to consider and, if thought fit, pass the Resolution to approve the terms on which the Tender Offer will be effected. A notice convening the General Meeting is set out at the end of the Circular. Participating in the Tender Offer If you are a Shareholder and hold your Ordinary Shares in Certificated Form and you wish to tender all or any of your Ordinary Shares, you should complete the Tender Form in accordance with the instructions printed on it and in Part V of the Circular and return it by post in the accompanying reply-paid envelope (for use in the UK only) to the Receiving Agent, at the Pavilions, Bridgewater Road, Bristol, BS99 6AH so as to be received by no later than 1:00 p.m. (London time) on Thursday 20 June 2024, together with your share certificate(s) in respect of the Ordinary Shares tendered. If you are a Shareholder and hold your Ordinary Shares in Uncertificated Form and you wish to tender all or any of your Ordinary Shares, you should send the TTE Instruction through CREST so as to settle by no later than 1:00 p.m. (London time) on Thursday 20 June 2024. Any ADS Holder who holds ADSs on the books of the Depositary who wishes to tender pursuant to the Tender Offer should properly complete and duly execute a Letter of Transmittal (or facsimile thereof), together with any required signature guarantees and any other required documents, and deliver such documents to the tender agent for the ADSs, Citibank, N.A. (the "Tender Agent"), at the appropriate address set forth in the Letter of Transmittal so as to be received no later than 5:00 p.m. (New York City time) on the ADS Closing Date (unless the Tender Offer is extended). In addition, the ADRs evidencing the tendered ADSs must be received by the Tender Agent at the appropriate address or be delivered pursuant to the procedures for book-entry transfer set forth below (and a confirmation of receipt of such transfer must be received by the Tender Agent) so as to be received no later than 5:00 p.m. (New York City time) on the ADS Closing Date. If the ADSs are held through a broker, dealer, commercial bank, trust company or other securities intermediary and the ADS Holder wishes to participate in the Tender Offer, such ADS Holder should provide tender instructions in accordance with the instructions provided by such intermediary in sufficient time so as to ensure that such intermediary can provide such instructions to the Tender Agent so as to be received no later than 5:00 p.m. (New York City time) on the ADS Closing Date (unless the Tender Offer is extended). Timetable A summary expected timetable of principal events is set out in Appendix I to this announcement. Shareholder Helpline If you have any questions about the procedure for tendering Ordinary Shares, please call Computershare Investor Services PLC on +44 370 707 4040. Calls are charged at the standard geographic rate and will vary by provider. Calls outside the United Kingdom will be charged at the applicable international rate. The helpline is open between 8:30 a.m. – 5:30 p.m., London time Monday to Friday, excluding public holidays in England and Wales. Please note that Computershare Investor Services PLC will be unable to give advice on the merits of the Tender Offer or to provide financial, investment or taxation advice. The Information Agent with respect to the Tender Offer for ADSs and Ordinary Shares in the United States is Georgeson LLC. If you are an ADS holder, an ordinary shareholder, bank, broker or institutional holder in the United States and have questions on how you can participate in the Tender Offer, please call the Information Agent at (+1) 866 529 2770 (toll-free) and (+1) 781 896 6940 (from other countries) from 9 a.m. to 8 p.m. New York City time Monday to Friday, and Saturday from 10 a.m. to 2 p.m. New York City time. About PureTech Health PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech’s R&D engine has resulted in the development of 29 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points. For more information, visit www.puretechhealth.com or connect with us on X (formerly Twitter) @puretechh. Additional Information for US Investors The Tender Offer qualifies as a “Tier II” offer in accordance with Rule 14d-1(d) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and, as a result, is exempt from certain provisions of otherwise applicable US statutes and rules relating to tender offers. US and English law and practice relating to tender offers are different in certain material respects. The Company intends to rely on the Tier II exemption from Rule 14e-1(c) on prompt payment where the Company will follow English law and practice. This communication is provided for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell any securities of the Company pursuant to the Tender Offer or otherwise. The Tender Offer will only be made pursuant to the Circular and other related materials filed as part of the Tender Offer Statement on Schedule TO, in each case as may be amended or supplemented from time to time. The Company’s security holders are advised to carefully read these documents, and any amendments to these documents, in their entirety before making any decision with respect to the Tender Offer, because these documents will contain important information. The Company’s security holders may obtain copies of these documents and other documents filed with the SEC for free at the SEC’s website at www.sec.gov. In addition, the Company will provide copies of such documents free of charge to its security holders. In accordance with normal market practice in the UK and pursuant to Rule 14e-5(b)(12) under the Exchange Act, the Company or its nominees or brokers or Jefferies or its affiliates may from time to time make certain purchases of, or arrangements to purchase Ordinary Shares outside the United States, otherwise than pursuant to the Tender Offer, before or during the period in which the Tender Offer remains open for acceptance, such as in open market purchases at prevailing prices or privately negotiated purchases at negotiated prices. Such purchases, or arrangements to purchase will comply with all applicable rules in the UK, including the Listing Rules of the FCA and the Admission and Disclosure Standards of the London Stock Exchange. Any information about such purchases will be disclosed as required in the UK and the US and, if required, will be reported via a Regulatory Information Service and will be available to all investors (including US investors) on the London Stock Exchange website at www.londonstockexchange.com. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements that relate to our expectations around our therapeutic candidates and approach towards addressing major diseases, our future prospects, developments, and strategies, and statements regarding the intent, belief or current expectations regarding the Tender Offer. The forward-looking statements are based on current expectations and are subject to known and unknown risks, uncertainties and other important factors that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks, uncertainties and other important factors described under the caption "Risk Factors" in our Annual Report on Form 20-F for the year ended December 31, 2023 filed with the SEC and in our other regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of the Company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law and regulatory requirements, we disclaim any obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise. Other Important Notices This announcement is neither an offer to purchase nor a solicitation of an offer to sell Ordinary Shares (including Ordinary Shares represented by ADSs). The Tender Offer is made only pursuant to the Circular, the related Tender Form with respect to the Ordinary Shares and the related Letter of Transmittal with respect to the ADSs. The Tender Offer is not being made to, holders of Ordinary Shares (including Ordinary Shares represented by ADSs) residing in any jurisdiction in which the making of the Tender Offer would not be in compliance with the laws of that jurisdiction. In any jurisdiction where the securities, "blue sky", or other laws require the Tender Offer to be made by a licensed broker or dealer, the Tender Offer will be deemed to be made on behalf of Jefferies International Limited by one or more registered brokers or dealers licensed under the laws of such jurisdiction. Jefferies, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom (“FCA”), is acting exclusively for the Company as financial advisor and broker in connection with the Tender Offer and is not, and will not be, responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice in connection with the Tender Offer or any other matters set out in this announcement. Apart from the responsibilities and liabilities, if any, which may be imposed on Jefferies under the Financial Services and Markets Act 2000, as amended or the regulatory regime established thereunder: (i) neither Jefferies or any persons associated or affiliated with Jefferies accepts any responsibility whatsoever or makes any warranty or representation, express or implied, in relation to the contents of this announcement, including its accuracy, completeness or verification or for any other statement made or purported to be made by, or on behalf of it, the Company or the directors of the Company, in connection with the Company and/or the Tender Offer; and (ii) Jefferies accordingly disclaims, to the fullest extent permitted by law, all and any liability whatsoever, whether arising in tort, contract or otherwise (save as referred to above) which it might otherwise be found to have in respect of this announcement or any such statement. PureTech Health plc Proposed capital return of $100 million by way of a Tender Offer at 250 pence per Ordinary Share and Notice of General Meeting 1. INTRODUCTION On 18 March 2024, the Company announced that it will receive approximately $293 million gross proceeds from the sale of its remaining stake in Karuna Therapeutics, Inc. (“Karuna”) pursuant to the completed acquisition of Karuna by Bristol Myers Squibb which has acquired all outstanding common stock of Karuna. On 19 March 2024, the Company announced a proposed capital return of $100 million to Shareholders by way of a Tender Offer and subsequent repurchase of Ordinary Shares (including Ordinary Shares represented by ADSs) by the Company at a fixed tender price of 250 pence per Ordinary Share. The capital return of $100 million represents approximately 14 percent of the Company’s market capitalisation based on the Company’s closing share price as at 18 March 2024, being the date prior to the announcement of the proposed Tender Offer. The Company’s $50 million share buyback program completed on 7 February 2024, which, together with the proposed Tender Offer, would constitute $150 million of capital returned to Shareholders, representing approximately 20 percent of the Company’s market capitalisation as at 16 May 2024, being the Latest Practicable Date before publication of the Circular. The fixed Tender Price of 250 pence per Ordinary Share (equivalent to £25.00 per ADS) represents: a premium of 25 percent to PureTech’s trailing volume weighted average price per Ordinary Share over the three days prior to 19 March 2024, the date of PureTech’s initial announcement of the Tender Offer proposals; and a premium of 12.6 percent to the closing price of 222 pence per Ordinary Share on the Latest Practicable Date. Shareholders are not required to tender any or all of their Ordinary Shares (including Ordinary Shares represented by ADSs) if they do not wish to do so. There is no guarantee that the Tender Offer will return the full sum of $100 million to Shareholders. If the full $100 million is not returned through the Tender Offer, then, if there is sufficient surplus, the Board intends to return such surplus by way of a special dividend following completion of the Tender Offer, without interest, less any applicable withholding taxes and subject to market and industry conditions at the time and any relevant legal restrictions (the “Special Dividend”). Shareholder approval for the maximum number of Ordinary Shares which may be acquired and the fixed price at which Ordinary Shares may be acquired at a General Meeting to be held at 11:00 a.m. (New York City time) (4:00 p.m. (London time)) on 6 June 2024. The Notice of General Meeting is set out in the Circular. The Circular contains details of the procedure that should be followed by those Shareholders and ADS Holders wishing to participate in the Tender Offer. Shareholders and ADS Holders should note that any amounts paid to Shareholders or ADS Holders in respect of the Tender Offer and the Special Dividend (if any) may be subject to US withholding tax unless the appropriate certifying forms can be provided by such Shareholder or ADS Holder to establish an exemption from, or a reduction of, such US withholding tax. Shareholders and ADS Holders should refer to Part VI of the Circular for further information on the important tax considerations in respect of the Tender Offer and Special Dividend (if any), together with instructions on the arrangements to provide appropriate certifying forms. 2. TENDER OFFER 2.1 Background to and reasons for the Tender Offer On 18 March 2024, the Company announced the completion of the sale of its stocks in Karuna to Bristol Myers Squibb, Inc. (“BMS”) for a total equity value of approximately $14 billion (the “Transaction”). The Company received approximately $293 million gross proceeds from the sale of its Karuna equity position. In addition, the Company is eligible to receive further milestones and royalty payments based on certain regulatory and commercial successes. On 25 April 2024, the Company published its annual report and accounts for the year ending 31 December 2023 (“2023 Annual Report”). The Annual Report included an update on subsequent events following the financial year end up to 25 April 2024. The Company’s performance and outlook has continued in line with expectations since the publication of the 2023 Annual Report. As stated in the 2023 Annual Report, the Company determines its capital allocation with a measured approach that balances support for its current internal and founded entity programs and the funding of future innovation, with the goal of maximising Shareholder returns. The Board will assess ongoing opportunities to improve Shareholder returns, including additional capital returns to Shareholders from future monetisation events, while maintaining a cash runway of at least three years to support its internal programs, founded entities, future innovation and operational needs. The Board has determined that the Tender Offer would be the most suitable way of returning a proportion of the proceeds of the Transaction to Shareholders in a quick and efficient manner, taking account of the relative costs, complexity and timeframes of the possible methods available. Subject to the passing of the Resolution by Shareholders at the General Meeting, the Directors will give Shareholders the opportunity to tender Ordinary Shares (including Ordinary Shares represented by ADSs) through the Tender Offer for cash only. The Resolution will give the Directors authority to acquire up to 33,500,000 Ordinary Shares at a fixed tender price of 250 pence per Ordinary Share (the “Tender Price”). Tenders will only be accepted at the Tender Price. Subject to satisfaction of the Tender Conditions to the Tender Offer, Ordinary Shares which are successfully tendered under the Tender Offer will be purchased at the Tender Price. If the full amount of the $100 million is not returned through the Tender Offer, and if there is sufficient surplus, the Board intends to return such surplus by way of the Special Dividend. The Issued Ordinary Share Capital on the Latest Practicable Date was 270,761,077 Ordinary Shares (excluding 18,707,082 Ordinary Shares held in treasury). If the Tender Offer is implemented in full, this will result in the purchase and cancellation of up to 33,500,000 Ordinary Shares (including Ordinary Shares represented by ADSs) (representing approximately 12 percent of the Issued Ordinary Share Capital of the Company on the Latest Practicable Date). Shareholders should note that the Issued Ordinary Share Capital numbers referred to in this paragraph take no account of any dilution which may be caused by the Share Plans, which is explained in further detail in the Circular. 2.2 Benefits of the Tender Offer The Board considered various options for returning cash to Shareholders and determined that the Tender Offer, together with any subsequent Special Dividend (if any), would be the most appropriate means of returning cash to Shareholders. In particular: the Tender Offer provides those Shareholders who wish to sell Ordinary Shares (including Ordinary Shares represented by ADSs) with the opportunity to do so at a market-driven price with a premium as at the Latest Practicable Date; the Tender Offer enables those Shareholders who do not wish to receive capital at this time to maintain their full investment in the Company; the Tender Price represents a premium of 25 percent to PureTech’s trailing volume weighted average price per Ordinary Share over the three days prior to 19 March 2024, the date of PureTech’s initial announcement of the Tender Offer proposals and a premium of 12.6 percent to the closing price of 222 pence per Ordinary Share on the Latest Practicable Date; the Tender Offer is available to all Shareholders regardless of the size of their shareholdings; and the Tender Offer allows the Company to broaden the scope of the return of capital to include Ordinary Shares held by those Shareholders whose Ordinary Shares (including Ordinary Shares represented by ADSs) might not be purchased by the Company through a share purchase programme. 2.3 Principal Terms of the Tender Offer Jefferies will implement the Tender Offer by acquiring, as principal, the successfully tendered Ordinary Shares (including Ordinary Shares represented by ADSs) at the Tender Price. Ordinary Shares (including Ordinary Shares represented by ADSs) purchased by Jefferies pursuant to the Tender Offer will be purchased as principal and such purchases will be market purchases in accordance with the provisions of the Act, the Prospectus Regulation Rules, the Listing Rules, the rules of the London Stock Exchange, the Disclosure Guidance and Transparency Rules and the Takeover Code. Immediately following completion of the Tender Offer, Jefferies shall exercise its right to sell such Ordinary Shares (including Ordinary Shares represented by ADSs) to the Company, at the Tender Price, pursuant to the Option Agreement. If Jefferies does not exercise its right to require the Company to purchase such Ordinary Shares (including Ordinary Shares represented by ADSs), the Company has the right to require Jefferies to sell such Ordinary Shares (including Ordinary Shares represented by ADSs) to it at the Tender Price. Purchases of Ordinary Shares by the Company pursuant to the Option Agreement will also be market purchases in accordance with the provisions of the Act, the Prospectus Regulation Rules, the Listing Rules, the rules of the London Stock Exchange, the Disclosure Guidance and Transparency Rules and the Takeover Code. All of the Ordinary Shares (including Ordinary Shares represented by ADSs) purchased by the Company pursuant to the Option Agreement in connection with the Tender Offer will be cancelled. Further details on the Option Agreement are set out in Part VIII of the Circular. Shareholders can decide whether they want to tender all, some or none of their Ordinary Shares (including Ordinary Shares represented by ADSs) in the Tender Offer. As at the date of this announcement, it is proposed that a maximum of 33,500,000 Ordinary Shares (including Ordinary Shares represented by ADSs) be purchased under the Tender Offer at the Tender Price, representing approximately 12 percent of the Company’s Issued Ordinary Share Capital as at 16 May 2024, being the Latest Practicable Date, for a maximum aggregate amount of $100 million. The maximum amount of $100 million will be translated into a pounds sterling amount on the Ordinary Share Closing Date, which pounds sterling amount shall determine the maximum number of shares to be accepted for payment in the Tender Offer. Tenders in respect of Ordinary Shares may only be made at the Tender Price and tenders of ADSs may only be made at the ADS Tender Price. Each ADS represents 10 Ordinary Shares. Accordingly, the amount an ADS Holder will receive for each ADS in respect of which the underlying Ordinary Shares are successfully tendered under the Tender Offer will be an amount of £25.00 (twenty five pounds sterling), being ten times the Tender Price, with such amounts to be converted by the Tender Agent from pounds sterling into US dollars and paid to the ADS Holder in US dollars (the “ADS Tender Price”). For illustrative purposes, the ADS Tender Price is equivalent to $31.68 per ADS (each of which represents 10 Ordinary Shares), based on an exchange rate of pounds sterling to US dollars of £1.00 to $1.2671 (being the exchange rate on the Latest Practicable Date). The actual amount of US dollars such ADS Holder receives will depend upon the exchange rate prevailing at the time the Tender Agent converts the pounds sterling amount into US dollars. ADS Holders should be aware that the US dollar/pound sterling exchange rate that is prevailing on the date on which ADSs are tendered may be different than the US dollar/pound sterling exchange rate prevailing at the time the pounds sterling are converted into US dollars. Successfully tendered Ordinary Shares that are accepted for payment will be cancelled. Shareholders do not have to tender any Ordinary Shares if they do not wish to do so, and ADS Holders do not have to tender any ADSs if they do not wish to do so. ADS Holders should refer to Part VIII of the Circular. The Tender Offer will close at 1:00 p.m. (London time) on Thursday 20 June 2024 (and for ADS Holders at 5:00 p.m. (New York City time) on Tuesday 18 June 2024) and tenders received after those times (as appropriate) will not be accepted (unless the Tender Offer is extended). Shareholders should note that, once tendered, Ordinary Shares may not be sold, transferred, charged, or otherwise disposed of other than in accordance with the Tender Offer. Shareholders who are in any doubt as to the contents of this announcement or as to the action to be taken should immediately consult their stockbroker, bank manager, solicitor, accountant, or other independent financial advisor authorised under FSMA, if taking advice in the UK or, if resident in another jurisdiction, from another appropriately authorised independent financial or professional advisor. 2.4 Number of Ordinary Shares to be purchased If the aggregate value at the Tender Price of all validly tendered Ordinary Shares (including Ordinary Shares represented by ADSs) exceeds $100 million (based on the applicable exchange rate of US dollars to pounds sterling on the Ordinary Share Closing Date), or the number of validly tendered Ordinary Shares (including Ordinary Shares represented by ADSs) exceeds 33,500,000 Ordinary Shares, acceptances of validly tendered Ordinary Shares (including Ordinary Shares represented by ADSs) will be scaled-down pro-rata to the total number of Ordinary Shares (including Ordinary Shares represented by ADSs) so tendered by that Shareholder, as described in paragraphs 2.14 and 2.15 of Part V of the Circular. Accordingly, where scaling-down applies, there is no guarantee that all of the Ordinary Shares (including Ordinary Shares represented by ADSs) which are tendered will be accepted for purchase. Successfully tendered Ordinary Shares will be purchased free of commission and dealing charges. Any Ordinary Shares repurchased by the Company from Jefferies following the purchase by Jefferies will be cancelled. Any rights of Shareholders who choose not to tender their Ordinary Shares or ADSs will be unaffected. Subject to any applicable law and regulatory requirements (including the rules and regulations of the London Stock Exchange and SEC), the Company reserves the right at any time prior to the expiration of the Tender Offer, and with the prior consent of Jefferies, to extend the period during which the Tender Offer is open, based on market conditions and/or other factors. 2.5 Circumstances in which the Tender Offer may not proceed There is no guarantee that the Tender Offer will take place. The Tender Offer is conditional on, among other things: The Company has reserved the right at any time prior to the expiration of the Tender Offer, with the prior consent of Jefferies, to extend the period during which the Tender Offer is open and/or vary the aggregate value of the Tender Offer, based on market conditions and/or other factors, subject to compliance with applicable legal and regulatory requirements. Any such decision will be announced by the Company through a Regulatory Information Service and by a press release in the US. The Company may terminate the Tender Offer if the Company concludes, in its reasonable discretion, one or more of the Tender Conditions set out in paragraph 2.1 of Part V of this Tender Offer have not been satisfied. 2.6 Results announcement As set out in the expected timetable below, it is expected that the results of the Tender Offer will be announced on 24 June 2024, subject to the satisfaction of the Tender Conditions. Settlement is then expected to take place as set out in the timetable. 2.7 Full terms and conditions of the Tender Offer Full details of the Tender Offer, including the terms and conditions on which it is made, are set out in Part V of the Circular. Some questions and answers related to the Tender Offer are set out in Part IV of the Circular. Further details of the Tender Offer in respect of the ADSs, including some questions and answers relating to the tender of the Ordinary Shares represented by ADSs and certain terms and conditions on which the Tender Offer is made in respect of the ADSs, are set out in Part VIII of the Circular. 3. GENERAL MEETING TO APPROVE THE RESOLUTION The Tender Offer requires the approval by Shareholders of the Resolution at the General Meeting. For this purpose, the Company is convening the General Meeting for 11:00 a.m. (New York City time) (4:00 p.m. (London time)) on 6 June 2024 to be held at 6 Tide Street, Boston, Massachusetts, 02210, United States to consider and, if thought fit, pass the Resolution to authorise and to approve the terms on which the Tender Offer will be effected. A notice convening the General Meeting is set out at the end of the Circular. The General Meeting has been convened to consider and, if thought fit, approve a resolution authorising the Company to purchase up to a maximum of 33,500,000 Ordinary Shares, representing approximately 12 percent of the Issued Ordinary Share Capital as at the Latest Practicable Date. The Company will not purchase Ordinary Shares pursuant to the Tender Offer unless the Resolution is duly passed. A summary of action to be taken by Shareholders in connection with the General Meeting is set out in paragraph 9 of Part III of the Circular, together with the notes to the Notice of General Meeting as set out in Part X of the Circular. 4. TAX Shareholders and ADS Holders should note that, due to the circumstances of its formation and the application of Section 7874 of the United States Internal Revenue Code of 1986, as amended (“Code”), the Company is treated as a US domestic corporation for US federal income tax purposes. Accordingly, the Company is subject to US federal income tax as if it were a US corporation, and distributions made by the Company (including certain payments in respect of the Tender Offer that are treated as distributions for US federal income tax purposes) are generally treated as US-source dividends. As a result, both US Holders and Non-US Holders may be subject to US federal income tax withholding on receipt of cash proceeds from any tendered Ordinary Shares or ADSs accepted in the Tender Offer and the Special Dividend (if any). The attention of Shareholders is drawn to Part VI of the Circular, which provides a summary of certain material UK tax and US federal income tax consequences for Shareholders of accepting the Tender Offer or receipt of the Special Dividend (if any). Part VI also provides additional information to Shareholders on Section 302 Certifications, IRS Form W-9 and IRS Form W-8. This information is not tax advice. Shareholders and ADS Holders should consult their professional tax advisors, in particular regarding their individual tax position and the exemptions or reductions of US withholding tax that may be available to them. 5. OVERSEAS SHAREHOLDERS The attention of Shareholders who are not resident in, or nationals or citizens of, the United Kingdom is drawn to paragraph 5 of Part V of the Circular. 6. BOARD INTENTIONS The Company’s Chief Executive Officer, Dr Bharatt Chowrira, has confirmed that he does not intend to tender any of his current individual beneficial holding of Ordinary Shares through the Tender Offer. The remainder of the Board, comprising the Company’s interim chair and the Company’s non-executive directors, are each considering their individual position and may tender Ordinary Shares of which they are the registered or beneficial holder, or otherwise hold on trust as trustees (as applicable), under the Tender Offer. 7. RECOMMENDATION BY THE BOARD The Directors consider that the Tender Offer is in the best interests of the Shareholders as a whole. Accordingly, the Board recommends that Shareholders vote in favour of the Resolution, as the Directors intend to do for their respective individual beneficial holdings of, in aggregate, 7,938,094 Ordinary Shares, representing approximately 3 per cent. of the Issued Ordinary Share Capital of the Company as at the Latest Practicable Date. The Board makes no recommendation to Shareholders in relation to participation in the Tender Offer itself. Whether or not Shareholders decide to tender all, or any, of their Ordinary Shares (including Ordinary Shares represented by ADSs) will depend on, among other things, their view of the Company’s prospects and their own individual circumstances, including their own financial and tax position. Shareholders are required to take their own decision and are recommended to consult with their duly authorised independent financial or professional advisor. Appendix I Expected Timetable Announcement of launch of the Tender Offer, publication of the Circular and the Notice of General Meeting 20 May 2024 File Schedule TO with the SEC 20 May 2024 Tender Offer opens 20 May 2024 Latest time and date for receipt by the Depositary of voting instructions in respect of ADSs for the General Meeting 10:00 a.m. New York City time on 31 May 2024 Latest time and date for receipt of Forms of Proxy for the General Meeting 11:00 a.m. New York City time (4:00 p.m. London time) on 4 June 2024 General Meeting 11:00 a.m. New York City time (4:00 p.m. London time) on 6 June 2024 Announcement of results of the General Meeting 6 June 2024 Latest time and date for receipt by Tender Agent of Letters of Transmittal for ADSs and book-entry transfer of ADSs 5:00 p.m. New York City time on 18 June 2024 Latest time and date for receipt of Tender Forms and share certificates in relation to the Tender Offer 1:00 p.m. London time on 20 June 2024 Latest time and date for receipt of TTE Instructions in relation to the Tender Offer 1:00 p.m. London time on 20 June 2024 Announcement of results of the Tender Offer 24 June 2024 Purchase of Ordinary Shares under the Tender Offer 24 June 2024 CREST accounts credited with Tender Offer proceeds in respect of uncertificated Ordinary Shares by 25 June 2024 CREST accounts credited for revised, uncertificated holdings of Ordinary Shares (or, in the case of unsuccessful tenders, for entire holdings of Ordinary Shares) by 25 June 2024 Cheques despatched in respect of Tender Offer proceeds for Certificated Ordinary Shares by 3 July 2024 Credit of proceeds in respect of book-entry ADSs by 3 July 2024 Despatch of balance of ADSs by 3 July 2024 Cheques despatched in respect of Tender Offer proceeds for Certificated ADSs by 3 July 2024 Return of share certificates in respect of unsuccessful tenders of Certificated Ordinary Shares by 3 July 2024 Despatch of balancing share certificates (in respect of Certificated Ordinary Shares) for revised, certificated holdings in the case of partially successful tenders by 3 July 2024 Notes: The dates and times set forth above are in accordance with English law and practice and are subject to the Company’s right or, upon certain conditions set forth in the US securities laws, the Company’s obligation to extend or amend the Tender Offer. References to times in this timetable are to London time (British Summer Time (BST)) or New York City time (Eastern Daylight Time (EDT)) (as stated). Definitions The following definitions apply throughout this announcement, unless stated otherwise: Act the Companies Act 2006 of England and Wales, as amended from time to time ADR American Depositary Receipt representing ADSs ADS American Depositary Share, each representing 10 Ordinary Shares ADS Closing Date 5:00 p.m. New York City time on Tuesday 18 June 2024, unless the Tender Offer is extended ADS Holders the holder(s) of ADSs from time to time ADS Tender Price an amount of £25.00 (twenty five pounds sterling), being ten times the Tender Price, with such amounts to be converted by the Tender Agent from pounds sterling into US dollars and paid to the ADS Holder in US dollars BMS Bristol Myers Squibb, Inc. Board the Company’s board of directors as at the date of this announcement Certificated Form or Certificated a share, title to which is recorded in the relevant register of the share concerned as being held in certificated form (that is, not in CREST) Circular the document mailed on the date of this announcement to the Shareholders and ADS Holders with details of the Tender Offer Code the United States Internal Revenue Code of 1986, as amended Company PureTech Health plc, a public limited company incorporated in England with registered number 09582467 and registered office C/O Tmf Group, 13th Floor, One Angel Court, London, EC2R 7HJ, United Kingdom Company’s Registrar’s Helpline +44 (0)370 707 4040, the helpline available to Shareholders in connection with the Tender Offer in respect of Ordinary Shares and operated by Computershare Investor Services PLC, in its capacity as, the Company’s Registrar and Receiving Agent Company’s Registrar Computershare Investor Services PLC CREST the paperless settlement procedure operated by Euroclear enabling system securities to be evidenced otherwise than by certificates and transferred otherwise than by written instrument Depositary Citibank, N.A., located at 388 Greenwich Street, New York, New York, 10013, United States Directors the directors of the Company on the date of this announcement (or, where the context requires, the directors of the Company from time to time) Euroclear Euroclear UK & International Limited, the operator of CREST Exchange Act United States Securities Exchange Act of 1934, as amended FCA the Financial Conduct Authority of the United Kingdom FSMA the Financial Services and Markets Act 2000, as amended from time to time General Meeting the general meeting of the Company to be held at 6 Tide Street, Boston, Massachusetts, 02210, United States, at 11:00 a.m. (New York City time) (4:00 p.m. (London time) on 6 June 2024, or any adjournment thereof, notice of which is set out in the Circular Information Agent Georgeson LLC of 1290 avenue of the Americas, 9th floor, New York, NY 10104, United States Issued Ordinary Share Capital the Company’s issued ordinary share capital, excluding any treasury shares from time to time Jefferies Jefferies International Limited Karuna Karuna Therapeutics, Inc. Latest Practicable Date 16 May 2024, being the latest practicable date prior to this announcement Letter of Transmittal the Letter of Transmittal issued with the Circular to registered ADS Holders in connection with the Tender Offer Listing Rules the listing rules made under Part VI of FSMA (and contained in the FCA’s publication of the same name), as amended from time to time London Stock Exchange London Stock Exchange plc Non-US Holder has the meaning given to it in paragraph 1.5 of section B of Part VI of the Circular Notice of General Meeting the notice of the General Meeting which appears in Part X of the Circular Option Agreement the option agreement dated 20 May 2024, between Jefferies and the Company Ordinary Share Closing Date 1:00 p.m. London time on Thursday 20 June 2024 in respect of Ordinary Shares, unless the Tender Offer is extended Ordinary Shares the ordinary shares of one pence each in the capital of the Company Overseas Shareholders a Shareholder who is a resident in, or a national or citizen of, a jurisdiction outside the United Kingdom Prospectus Regulation Rules the prospectus regulation rules made under Part VI of FSMA (and contained in the FCA’s publication of the same name), as amended from time to time Receiving Agent Computershare Investor Services PLC, at The Pavilions Bridgwater Road, Bristol, BS99 6AH, United Kingdom Register the Company’s register of members Regulatory Information Service a service approved by the FCA for the distribution to the public of regulatory announcements and included within the list maintained on the FCA’s website Resolution the special resolution to be proposed at the General Meeting, as set out in the Notice of General Meeting SEC the United States Securities and Exchange Commission Section 302 Certification means the Section 302 Certification of Treatment of Tender Payment made available to holders of Ordinary Shares and ADS Shareholders the holders of the Ordinary Shares or ADSs, as applicable, from time to time Special Dividend a special dividend that may be returned following completion of the Tender Offer if the full $100 million is not returned through the Tender Offer and the Board determines there is sufficient surplus to return such, without interest, less any applicable withholding taxes and subject to market and industry conditions at the time and any relevant legal restrictions Takeover Code the City Code on Takeovers and Mergers Tender Agent Citibank, N.A., located at 388 Greenwich Street, New York, New York, 10013, United States Tender Conditions the conditions of the Tender Offer as set out in Part V and Part VIII of the Circular Tender Form the form enclosed with the Circular for use by Ordinary Shareholders who hold Ordinary Shares in Certificated form in connection with the Tender Offer Tender Offer the invitation to Shareholders to tender Ordinary Shares (including Ordinary Shares represented by ADSs) on the terms and conditions set out in the Circular (and, where the context so requires, the associated repurchase of such Ordinary Shares by the Company from Jefferies) Tender Price 250 pence being the price per Ordinary Share (equivalent to £25.00 per ADS) Transaction the acquisition by BMS of the Company’s stocks in Karuna for a total equity value of approximately $14 billion Uncertificated Form or Uncertificated a share recorded on the Register as being held in uncertificated form in CREST and title to which, by virtue of the Uncertified Securities Regulations, may be transferred by means of CREST United Kingdom or UK the United Kingdom of Great Britain and Northern Ireland, its territories and dependencies United States, US or USA the United States of America, its territories and possessions, any state of the United States and the District of Columbia US dollar or USD or US$ or $ the lawful currency of the United States US Holders has the meaning given to it in paragraph 1.4 of section B of Part VI of the Circular THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF THE MARKET ABUSE REGULATION (EU 596/ 2014) AS IT FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED.
  • 05/20/2024

California Dreaming: Los Angeles leads Nation in Mosquito Complaints according to Orkin's 2024 Top Mosquito Cities List

  • Orkin releases ranking of most mosquito-prone cities and continues to combat the pest through its partnership with American Red Cross this summer ATLANTA, May 20, 2024 /PRNewswire/ -- Aspiring celebrities aren't the only ones flocking to Los Angeles—the city is claiming the top spot on Orkin's Top 50 Mosquito Cities List. New York City, Chicago, Dallas and Atlanta rounded out this year's top five cities. Of the 50 cities on the list, California was represented the most, with five cities making the top 50: Los Angeles (1), San Francisco (9), Sacramento (22), San Diego (27), and Fresno (50). This year's data was collected by tracking new residential mosquito treatments from April 1, 2023, to March 31, 2024. This data helps Orkin better understand how likely homeowners in each city are to have a mosquito problem. Mosquitoes thrive in warm, damp environments, which is why they become more of an issue in the spring and summer. Mosquitoes are drawn to standing water as a breeding ground to lay their eggs. These pests reproduce quickly, with mosquito larva reaching the adult stage in a matter of days or weeks. Mosquitoes aren't just a nuisance—they're dangerous. They are the deadliest animal on earth, causing more than 600,000 malaria-related deaths around the world each year, according to the Centers for Disease Control and Prevention. Mosquitoes also spread other serious illnesses, including West Nile virus, Eastern Equine Encephalitis, and Zika, all of which are threats to humans and animals. "Preventative services are the best way to reduce the risk that mosquitoes present," said Frank Meek, Orkin entomologist. "By targeting the problem at its source, homeowners can reduce the risk of mosquito-transmitted illnesses for their families and their communities." To help combat this problem, Orkin is teaming up with the American Red Cross for its annual Mosquitoes Don't Deserve a Drop campaign. This initiative helps bring awareness to the health risks associated with mosquitoes, while also maintaining the country's blood supply. For every mosquito control service purchased between May 20 to June 30, 2024, Orkin will donate $25 to the Red Cross, up to $250,000. This is the perfect window of time to begin pest control services as mosquito activity increases, and customers can know their treatment is helping a greater cause. Regular treatments are just one way homeowners can help repel mosquitos around their properties. Additional tips to prevent mosquito bites include: For more mosquito facts and prevention tips, visit Orkin.com. About Orkin, LLC Founded in 1901, Atlanta-based Orkin is an industry leader in essential pest control services and protection against termite damage, rodents and insects. Orkin has 358 owned and operated branch offices and 47 franchises in the U.S. The company also has international franchises and subsidiaries in Canada, Europe, Central America, South America, the Caribbean, the Middle East, Asia, the Mediterranean, Africa, and Mexico. Orkin is committed to protecting public health by helping prevent and control pests as well as educating consumers on the potential health risks posed by these pests. As such, since 2020, Orkin has partnered with the American Red Cross® to inform the public about the health threats of mosquitoes while boosting our country's blood supply through monetary contributions and blood donations. Orkin is committed to hiring the world's best to help protect the places where we live, work and play. Learn more about careers at Orkin here. Visit Orkin.com for additional information. Orkin is a wholly-owned subsidiary of Rollins Inc. (NYSE: ROL).
  • 05/20/2024

Here's Why You Should Retain Wynn Resorts (WYNN) Stock Now

  • Wynn Resorts, Limited (WYNN Quick QuoteWYNN - Free Report) will likely benefit from solid Macau performance, non-gaming businesses and development projects. Also, focus on strategic expansion plans bodes well. However, increased operating expenses are a concern.Let us discuss the factors that highlight why investors should retain the stock.Factors Likely to Drive GrowthWynn Resorts has been benefitting from solid Macau performance. Following the elimination of COVID-19 protective measures by Macau authorities in January 2023, visitation to Macau and the company's operations improved, leading to increased business volumes in first-quarter 2024. During the first quarter, Wynn Palace reported operating revenues of $586.9 million, up $217.5 million from $369.4 million in the same period in 2023. WYNN's operating revenues came in at $411.7 million, rising by $181.0 million from $230.7 million in the first quarter of 2023. Higher gaming volumes, increased hotel occupancy and restaurant covers backed the upside. The company stated that the positive momentum continued into the second quarter, with a 30% increase in mass drop per day in April (compared to April 2019) and a 99% hotel occupancy rate. The company reported a 30% rise in mass drop per day (compared with the same period in 2019) during May's Golden Week.Increased focus on non-gaming avenues bode well. In the first quarter, the company reported robust performance across non-gaming businesses with 16% year-on-year revenue growth, driven by a 21% increase in hotel revenues and strong casino volumes. The upside can be attributed to exceptional service levels, continuous property reinvestment and the unique Only at Wynn programming. The company registered positive momentum into April with increases in Drop, Handle and RevPAR (revenue per available room) on a year-on-year basis.In Macau's development realm, the company has started initial demolition and construction on its second concession project, the Destination Food Hall. It has also advanced in the design and planning stages for other major concession-related capital expenditure commitments, including a new event and entertainment center with a unique theater and show. These projects require various government approvals, leading to a wide range of potential CapEx outcomes in the near term. The company expects CapEx for these commitments to range between $350 million and $500 million from 2024 through 2025-end. The company believes that the proposed investments and projects will drive growth in the coming periods.The emphasis on the expansion of new markets bodes well. The company is considering greenfield development opportunities in New York City and potentially Thailand. In New York, a full-scale Wynn integrated resort at Hudson Yards is anticipated to generate significant tax revenue, tourism and employment. Despite delays in the RFA submission process, the company maintains interest in securing a location in Manhattan. In Thailand, the company is closely monitoring regulatory and licensing developments.ConcernsImage Source: Zacks Investment ResearchIn the past year, shares of Wynn Resorts have declined 10.8% compared with the industry’s 2.8% fall. A challenging macro environment mainly caused the downside.Increased operating expenses are a concern for the company. During the first quarter of 2024, the company’s total operating expenses came in at $1.5 billion compared with $1.25 billion reported in the prior-year period. The upside was primarily due to a rise in casino, room, food and beverage, retail and other and general and administrative expenses. Moving ahead, the company is cautious of inflation and interest rate fluctuations. Zacks Rank & Key PicksWynn Resorts currently carries a Zacks Rank #3 (Hold).Some better-ranked stocks in the Zacks Consumer Discretionary sector are:Strategic Education, Inc. (STRA Quick QuoteSTRA - Free Report) currently sports a Zacks Rank #1 (Strong Buy). STRA has a trailing four-quarter earnings surprise of 36.2%, on average. The stock has surged 50.3% in the past year. The Zacks Consensus Estimate for STRA’s 2024 sales and earnings per share (EPS) indicates an increase of 6.4% and 33.3%, respectively, from the year-ago levels.Royal Caribbean Cruises Ltd. (RCL Quick QuoteRCL - Free Report) currently sports a Zacks Rank of 1. RCL has a trailing four-quarter earnings surprise of 18.3%, on average. The stock has rallied 76.7% in the past year.The Zacks Consensus Estimate for RCL’s 2024 sales and EPS calls for growth of 16.6% and 61.9%, respectively, from the year-ago levels.Hasbro, Inc. (HAS Quick QuoteHAS - Free Report) presently sports a Zacks Rank of 1. The company has a trailing four-quarter earnings surprise of 17.5%, on average. The stock has gained 17.8% in the year-to-date period.The Zacks Consensus Estimate for HAS’ 2025 sales and EPS suggests an improvement of 4% and 14.4 %, respectively, from the year-ago levels. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>
  • 05/20/2024

American Strategic Investment Co. (NYC) Q1 2024 Earnings Call Transcript

  • American Strategic Investment Co. (NYSE:NYC ) Q1 2024 Earnings Conference Call May 10, 2024 11:00 AM ET Company Participants Curtis Parker - SVP Michael Anderson - CEO Mike LeSanto - CFO Conference Call Participants Bryan Maher - B. Riley Securities Operator Good morning, and welcome to the American Strategic Investment Company's First Quarter Earnings Call.
  • 05/10/2024

American Strategic Investment Co. Announces First Quarter 2024 Results

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”), a company that owns a portfolio of commercial real estate located within the five boroughs of New York City, announced today its financial and operating results for the first quarter ended March 31, 2024. First Quarter 2024 and Subsequent Event Highlights Revenue was consistent at $15.5 million for the first quarter of 2024 and 2023 Net loss attributable to common stockholders improved to $7.6 mi.
  • 05/10/2024

BELLEVUE CAPITAL PARTNERS, LLC LAUNCHES TENDER OFFER FOR SHARES OF AMERICAN STRATEGIC INVESTMENT CORP.

  • $9.25 Offer Represents 67% Premium to Recent Closing Price NEW YORK , May 7, 2024 /PRNewswire/ -- Bellevue Capital Partners, LLC ("Bellevue") announced today that it has launched a tender offer to purchase up to 125,000 shares of American Strategic Investment Co. (NYSE: NYC) ("ASIC") common stock at a price of $9.25 per share (the "Tender Offer"). The Tender Offer will close on July 5, 2024.
  • 05/07/2024

American Strategic Investment Co. Announces New Leasing, 87.2% Occupancy

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today that it completed one new license agreement in the first quarter for approximately 8,000 square feet, resulting in a portfolio occupancy of 87.2%. Additionally, the Company's leasing pipeline totals approximately 14,000 square feet. “Our focus on portfolio management resulted in occupancy growth of over 300 basis points at the end of the first quarter compared to last year,” said M.
  • 05/06/2024

American Strategic Investment Co. to Accelerate Evolution of Business Model

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today that it intends to accelerate its efforts to evolve and diversify its business. The Company has started the process to market for sale its 9 Times Square Midtown Manhattan asset (“9 Times Square”). In addition, the Company intends to market for sale its properties located at 123 William Street and 196 Orchard Street. These strategic dispositions are in furtherance of the Company's.
  • 04/30/2024

American Strategic Investment Co. Announces Release Date for First Quarter Results

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today it will release its financial results as of, and for the first quarter ended March 31, 2024, on Friday, May 10, 2024, before the New York Stock Exchange open. The Company will also host a webcast and conference call the same day at 11:00 a.m. ET to review results and provide commentary on business performance. A question-and-answer session will follow the prepared remarks. Dial-in.
  • 04/25/2024

American Strategic Investment Co. (NYC) Q4 2023 Earnings Call Transcript

  • American Strategic Investment Co. (NYSE:NYC ) Q4 2023 Earnings Conference Call April 2, 2024 2:00 PM ET Company Participants Curtis Parker - Senior Vice President Michael Anderson - Chief Executive officer Joe Marnikovic - Chief Financial Officer Conference Call Participants Bryan Maher - B. Riley Securities Operator Good morning and welcome to the American Strategic Investment Company's Fourth Quarter and Year-End 2023 Earnings Call.
  • 04/02/2024

American Strategic Investment Co. Announces Fourth Quarter 2023 Results

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”), a company that owns a portfolio of commercial real estate located within the five boroughs of New York City, announced today its financial and operating results for the fourth quarter and year ended December 31, 2023. Fourth Quarter 2023 and Subsequent Events Revenue was $15.4 million Net loss attributable to common stockholders was $73.9 million or $32.27 per share including a non-cash impairmen.
  • 04/01/2024

American Strategic Investment Co. Announces Release Date for Fourth Quarter and Full Year 2023 Results

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today it will release its financial results as of, and for the fourth quarter and year ended December 31, 2023, on Monday, April 1, 2024, after the close of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Tuesday, April 2, 2024, beginning at 2:00 p.m. ET, to discuss the fourth quarter and full year results and provide commentary on bus.
  • 03/11/2024

It's Time! 3 Overplayed REITs to Sell in February

  • Real estate boom-and-bust cycles are repetitive, and I'm afraid that we look set for another. What's my premise?
  • 02/25/2024

American Strategic Investment Co. Announces Changes to Board of Directors

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announces the following changes to its Board of Directors. Board member Abby Wenzel has announced that she will resign from the ASIC Board effective December 28, 2023, after serving as a director for more than nine years. Nicholas Radesca has been appointed to the Board as an independent director with immediate effect. Mr. Radesca has a long history of board memberships and has held numerous execu.
  • 12/29/2023

American Strategic Investment Co. (NYC) Q3 2023 Earnings Call Transcript

  • American Strategic Investment Co. (NYC) Q3 2023 Earnings Call Transcript
  • 11/12/2023

American Strategic Investment Co. Announces Third Quarter 2023 Results

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”), a company that owns a portfolio of commercial real estate located within the five boroughs of New York City, announced today its financial and operating results for the third quarter ended September 30, 2023. Third Quarter 2023 and Subsequent Event Highlights Revenue was $16.0 million compared to $15.9 million in the third quarter 2022 and $15.8 million in the second quarter of 2023 as new leases.
  • 11/09/2023

BELLEVUE CAPITAL PARTNERS, LLC ANNOUNCES FINAL RESULTS OF TENDER OFFER FOR SHARES OF AMERICAN STRATEGIC INVESTMENT CORP.

  • NEW YORK , Oct. 27, 2023 /PRNewswire/ -- Bellevue Capital Partners, LLC ("Bellevue") announced today the final results of its tender offer to purchase for cash up to 350,000 shares of American Strategic Investment Co. (NYSE: NYC) ("ASIC") common stock at a price of $10.25 per share (the "Tender Offer"), which expired at 11:59 p.m., New York City time, on October 26, 2023.
  • 10/27/2023

American Strategic Investment Co. Announces Release Date for Third Quarter 2023 Results

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today it will release its financial results as of, and for the third quarter ended, September 30, 2023, on Thursday, November 9, 2023, before the start of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Thursday, November 9, 2023, beginning at 11:00 a.m. ET, to discuss the third quarter results and provide commentary on business perfor.
  • 10/16/2023

American Strategic Investment Co. Completes Disposition of the Hit Factory

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today that it completed the sale of the property it owns at 421 W. 54th Street (the “Hit Factory”) for $4.5 million. “We are pleased to complete the sale of the Hit Factory, a vacant property that will provide approximately $4.2 million of cash proceeds for the Company and positively impacts the Company's property level operating expenses through the elimination of meaningful expenses as.
  • 10/12/2023

American Strategic Investment Co. Announces Response to Bellevue Capital Partners, LLC Tender Offer

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today that it has filed with the Securities and Exchange Commission (“SEC”) a Solicitation/Recommendation Statement on Schedule 14D-9 and Letter to Stockholders dated October 10, 2023, regarding the tender offer commenced by Bellevue Capital Partners, LLC (“Bellevue”) on September 27, 2023, to purchase up to 350,000 shares of the Company's Class A common stock at a price of $10.25 per sh.
  • 10/10/2023

BELLEVUE CAPITAL PARTNERS, LLC LAUNCHES TENDER OFFER FOR SHARES OF AMERICAN STRATEGIC INVESTMENT CORP.

  • $10.25 Offer Represents 64.8% Premium to Recent Closing Price NEW YORK , Sept. 27, 2023 /PRNewswire/ -- Bellevue Capital Partners, LLC ("Bellevue") announced today that it launched a tender offer to purchase up to 350,000 shares of American Strategic Investment Co. (NYSE: NYC) ("ASIC") common stock at a price of $10.25 per share (the "Tender Offer").
  • 09/27/2023

American Strategic Investment Co. Announces Disposition of the Hit Factory

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today that it has signed a definitive purchase and sale agreement to sell a property it owns at 421 W. 54th Street (the “Hit Factory”) for $4.5 million. The sale is expected to close in the fourth quarter, 2023. Net proceeds from the sale of the property, which is unencumbered, will be available for general corporate purposes. “We are pleased to reach an agreement to sell the vacant Hit.
  • 08/17/2023

American Strategic Investment Co. (NYC) Q2 2023 Earnings Call Transcript

  • American Strategic Investment Co. (NYSE:NYC ) Q2 2023 Earnings Call Transcript August 11, 2023 11:00 AM ET Company Participants Curtis Parker - Senior Vice President Michael Weil - Chief Executive Officer Christopher Masterson - Chief Financial Officer Conference Call Participants Bryan Maher - B. Riley Operator Good morning, and welcome to the American Strategic Investment Company Second Quarter Earnings Call.
  • 08/11/2023

American Strategic Investment Co. (NYC) Reports Q2 Loss, Misses Revenue Estimates

  • American Strategic Investment Co. (NYC) came out with a quarterly loss of $0.74 per share versus the Zacks Consensus Estimate of a loss of $0.67. This compares to loss of $6.72 per share a year ago.
  • 08/11/2023

American Strategic Investment Co. Announces Release Date for Second Quarter 2023 Results

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“NYC” or the “Company”) announced today it will release its financial results for the second quarter ended June 30, 2023 on Friday, August 11, 2023 before the start of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Friday, August 11, 2023, beginning at 11:00 a.m. ET, to discuss the second quarter results and provide commentary on business performance. The call will be.
  • 07/26/2023

American Strategic Investment Co. (NYC) Q1 2023 Earnings Call Transcript

  • American Strategic Investment Co. (NYSE:NYC ) Q1 2023 Earnings Conference Call May 12, 2023 11:00 AM ET Company Participants Curtis Parker - Senior Vice President Michael Weil - Chief Executive Officer Chris Masterson - Chief Financial Officer Conference Call Participants Bryan Maher - B. Riley Operator Good morning, and welcome to the American Strategic Investment Co.'s First Quarter 2023 Earnings Call.
  • 05/12/2023

American Strategic Investment (NYC) Reports Q1 Loss, Misses Revenue Estimates

  • American Strategic Investment (NYC) came out with a quarterly loss of $1.28 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $1.20 per share a year ago.
  • 05/12/2023

American Strategic Investment Co. Announces Release Date for First Quarter 2023 Results

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“NYC” or the “Company”) announced today it will release its financial results for the first quarter ended March 31, 2023, on Friday, May 12, 2023, before the start of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Friday, May 12, 2023, beginning at 11:00 a.m. ET, to discuss the first quarter results and provide commentary on business performance. The call will be condu.
  • 04/26/2023

American Strategic Investment Co. (NYC) Q4 2022 Earnings Call Transcript

  • American Strategic Investment Co. (NYSE:NYC ) Q4 2022 Earnings Conference Call March 16, 2023 11:00 AM ET Company Participants Curtis Parker - Senior Vice President Michael Weil - Chief Executive Officer Christopher Masterson - Chief Financial Officer Conference Call Participants Bryan Maher - B. Riley FBR Operator Good morning and welcome to the American Strategic Investment Co's Fourth Quarter and Year-End 2022 Earnings Call.
  • 03/16/2023

American Strategic Investment (NYC) Reports Q4 Loss, Tops Revenue Estimates

  • American Strategic Investment (NYC) delivered FFO and revenue surprises of 84.72% and 0.19%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 03/16/2023

American Strategic Investment Co. Announces Release Date for Fourth Quarter and Full Year 2022 Results

  • NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“NYC” or the “Company”) announced today it will release its financial results for the fourth quarter and year ended December 31, 2022 on Thursday, March 16, 2023 before the start of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Thursday, March 16, 2023, beginning at 11:00 a.m.
  • 03/01/2023

The State Of REITs: February 2023 Edition

  • The REIT sector sharply rebounded from a tough 2022 with an +11.77% total return in January 2023. Micro cap REITs (+16.16%) saw disproportionately strong gains in January, followed by double-digit returns for small caps (+11.79%), mid caps (+11.50%) and large caps (+10.07%).
  • 02/20/2023

Good Riddance, 2022

  • U.S. equity markets closed out their worst year since the Financial Crisis with a fourth-straight week of declines as Treasury yields jumped back to seven-week highs on renewed inflation and COVID concerns. Dragging its full-year declines to nearly 20%, the S&P 500 slipped 0.1% this week while the tech-heavy Nasdaq dipped another 0.4%, shedding nearly a third of its value in 2022.
  • 01/01/2023

New York City REIT, Inc. (NYC) Q3 2022 Earnings Call Transcript

  • New York City REIT, Inc. (NYSE:NYC ) Q3 2022 Earnings Conference Call November 15, 2022 11:00 AM ET Company Participants Curtis Parker - SVP Michael Weil - CEO Chris Masterson - CFO Conference Call Participants Bryan Maher - B. Riley Securities FBR Operator Good morning.
  • 11/15/2022

New York City REIT, Inc. (NYC) Reports Q3 Loss, Lags Revenue Estimates

  • New York City REIT, Inc. (NYC) delivered FFO and revenue surprises of -180% and 0.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 11/14/2022

New York City REIT: A Dangerous Dip To Buy

  • The REIT's conviction on office properties could be a significant cause for concern. Although the fund's debt gearing is well arranged. Its core funds from operations are receding.
  • 10/25/2022

New York City REIT Announces Release Date for Third Quarter 2022 Results

  • NEW YORK--(BUSINESS WIRE)--New York City REIT, Inc. (NYSE: NYC) (“NYC” or the “Company”) announced today it will release its financial results for the third quarter ended September 30, 2022 on Thursday, November 10, 2022 before the start of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Thursday, November 10, 2022, beginning at 11:00 a.m. ET, to discuss the third quarter results and provide commentary on business performance. The call will b
  • 10/07/2022

New York City REIT, Inc. (NYC) CEO Michael Weil on Q2 2022 Results - Earnings Call Transcript

  • New York City REIT, Inc. (NYSE:NYC ) Q2 2022 Earnings Conference Call August 12, 2022 11:00 AM ET Company Participants Louisa Quarto - Executive Vice President Michael Weil - Chief Executive Officer Chris Masterson - Chief Financial Officer Conference Call Participants Bryan Maher - B. Riley Securities Operator Good morning, and welcome to the New York City REIT Second Quarter Earnings Call.
  • 08/12/2022

New York City REIT, Inc. (NYC) Reports Q2 Loss, Tops Revenue Estimates

  • New York City REIT, Inc. (NYC) delivered FFO and revenue surprises of -83.33% and 1.44%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 08/12/2022

New York City REIT Announces Release Date for Second Quarter 2022 Results

  • NEW YORK--(BUSINESS WIRE)--New York City REIT, Inc. (NYSE: NYC) (“NYC” or the “Company”) announced today it will release its financial results for the second quarter ended June 30, 2022 on Friday, August 12, 2022 before the start of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Friday, August 12, 2022, beginning at 11:00 a.m. ET, to discuss the second quarter results and provide commentary on business performance. The call will be conducted
  • 07/08/2022

NYC REIT stock drops after dividend suspended to help fund leasing commitment, tenant improvement costs

  • Shares of New York City REIT Inc. NYC, -1.74% slid 1.7% in afternoon trading Friday, after the real estate investment trust that owns a portfolio of commercial real estate in New York, said it was "temporarily suspending" its dividend to help fund upfront costs of leasing commitments and tenant improvements. The REIT last paid a quarterly dividend of 10 cents a share in April.
  • 07/01/2022

New York City REIT's (NYC) CEO Michael Weil on Q1 2022 Results - Earnings Call Transcript

  • New York City REIT, Inc. (NYSE:NYC ) Q1 2022 Earnings Conference Call May 13, 2022 11:00 AM ET Company Participants Louisa Quarto – Executive Vice President Michael Weil – Chief Executive Officer Chris Masterson – Chief Financial Officer Conference Call Participants Bryan Maher – B. Riley Securities Operator Good morning.
  • 05/13/2022

New York City REIT, Inc. (NYC) Reports Q1 Loss, Tops Revenue Estimates

  • New York City REIT, Inc. (NYC) delivered FFO and revenue surprises of -87.50% and 0.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 05/13/2022

New York City REIT Announces Release Date for First Quarter 2022 Results

  • NEW YORK--(BUSINESS WIRE)--New York City REIT, Inc. (NYSE: NYC) (“NYC” or the “Company”) announced today it will release its financial results for the first quarter ended March 31, 2022 on Friday, May 13, 2022 before the start of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Friday, May 13, 2022, beginning at 11:00 a.m. ET, to discuss the first quarter results and provide commentary on business performance. The call will be conducted by NYC
  • 04/14/2022

New York City REIT, Inc. (NYC) CEO Edward Weil on Q4 2021 Results - Earnings Call Transcript

  • New York City REIT, Inc. (NYC) CEO Edward Weil on Q4 2021 Results - Earnings Call Transcript
  • 03/17/2022

New York City REIT, Inc. (NYC) Q4 FFO and Revenues Surpass Estimates

  • New York City REIT, Inc. (NYC) delivered FFO and revenue surprises of 1,425% and 50.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 03/17/2022

New York City REIT Announces Release Date for Fourth Quarter and Full Year 2021 Results

  • NEW YORK--(BUSINESS WIRE)--New York City REIT, Inc. (NYSE: NYC) (“NYC” or the “Company”) announced today it will release its financial results for the fourth quarter and full year ended December 31, 2021 on Thursday, March 17, 2022 before the start of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Thursday, March 17, 2022, beginning at 11:00 a.m. ET, to discuss the fourth quarter and full year results and provide commentary on business perfo
  • 02/22/2022

Buying 3 REITs For Far Less Than Their Properties Are Worth

  • Buying 3 REITs For Far Less Than Their Properties Are Worth
  • 12/20/2021

Bears are Losing Control Over New York City REIT, Inc. (NYC), Here's Why It's a 'Buy' Now

  • New York City REIT, Inc. (NYC) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
  • 11/29/2021

CVS To Close 900 Stores: Smart Move And REIT Landlords Benefit Too

  • CVS Health Corp. to close nearly 10% of its US locations over the next three years. In an agenda to improve profitability, the company plans to add new health services.
  • 11/24/2021

New York City REIT, Inc. (NYC) CEO Mike Weil on Q3 2021 Results - Earnings Call Transcript

  • New York City REIT, Inc. (NYC) CEO Mike Weil on Q3 2021 Results - Earnings Call Transcript
  • 11/12/2021

New York City REIT Announces Release Date for Third Quarter 2021 Results

  • NEW YORK--(BUSINESS WIRE)--New York City REIT, Inc. (NYSE: NYC) (“NYC” or the “Company”) announced today it will release its financial results for the third quarter ended September 30, 2021 on Friday, November 12, 2021 before the start of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Friday, November 12, 2021, beginning at 11:00 a.m. ET, to discuss the first quarter results and provide commentary on business performance. The call will be co
  • 10/20/2021

NYC'S 123 William Street Named Building of the Year by BOMA New York

  • NEW YORK--(BUSINESS WIRE)--New York City REIT, Inc. (NYSE: NYC) is pleased to announce that its property at 123 William Street in New York, NY has been named Building of the Year in the Operating Office Building 500,000 – 1,000,000 square foot category by the Building Owners and Managers Association of New York (“BOMA New York”). 123 William Street is a 545,000 square-foot office building in downtown Manhattan. Major tenants include government, financial and not-for-profit organizations. “We ar
  • 10/06/2021

New York City REIT's (NYC) CEO Mike Weil on Q2 2021 Results - Earnings Call Transcript

  • New York City REIT's (NYC) CEO Mike Weil on Q2 2021 Results - Earnings Call Transcript
  • 08/13/2021

New York City REIT Announces Release Date for Second Quarter 2021 Results

  • NEW YORK--(BUSINESS WIRE)--New York City REIT, Inc. (NYSE: NYC) (“NYC” or the “Company”) announced today it will release its financial results for the second quarter ended June 30, 2021 on Thursday, August 12, 2021 before the start of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Thursday, August 12, 2021, beginning at 10:00 a.m. ET, to discuss the first quarter results and provide commentary on business performance. The call will be conduc
  • 07/12/2021

New York City REIT, Inc. Announces Common Stock Dividend for Third Quarter 2021

  • NEW YORK--(BUSINESS WIRE)--New York City REIT, Inc. (NYSE: NYC) (“NYC”) announced today that it intends to continue to pay dividends on its shares of Class A common stock and Class B common stock at an annualized rate of $0.40 per share or $0.10 per share on a quarterly basis. NYC anticipates paying dividends authorized by its board of directors on its shares of common stock on a quarterly basis in arrears on the 15th day of the first month following the end of each fiscal quarter (unless other
  • 07/01/2021

New York City REIT: Much Better Prospects Abound

  • New York City REIT: Much Better Prospects Abound
  • 05/26/2021

New York City REIT, Inc. (NYC) CEO Mike Weil on Q1 2021 Results - Earnings Call Transcript

  • New York City REIT, Inc. (NYC) CEO Mike Weil on Q1 2021 Results - Earnings Call Transcript
  • 05/14/2021

New York City REIT Announces Release Date for First Quarter 2021 Results

  • NEW YORK--(BUSINESS WIRE)--New York City REIT, Inc. (NYSE: NYC) (“NYC” or the “Company”) announced today it will release its financial results for the first quarter ended March 31, 2021 on Thursday, May 13, 2021 before the start of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Thursday, May 13, 2021, beginning at 11:00 a.m. ET, to discuss the first quarter results and provide commentary on business performance. The call will be conducted by
  • 04/23/2021

New York City REIT, Inc. Announces Common Stock Dividend for Second Quarter 2021

  • NEW YORK--(BUSINESS WIRE)--New York City REIT, Inc. (NYSE: NYC) (“NYC”) announced today that it intends to continue to pay dividends on its shares of Class A common stock and Class B common stock at an annualized rate of $0.40 per share or $0.10 per share on a quarterly basis. NYC anticipates paying dividends authorized by its board of directors on its shares of common stock on a quarterly basis in arrears on the 15th day of the first month following the end of each fiscal quarter (unless other
  • 04/01/2021

New York City REIT Announces Fourth Quarter and Full Year 2020 Results

  • NEW YORK--(BUSINESS WIRE)--New York City REIT, Inc. (NYSE: NYC) (“NYC” or the “Company”), a real estate investment trust that owns a portfolio of high-quality commercial real estate located within the five boroughs of New York City, announced today its financial and operating results for the fourth quarter and year ended December 31, 2020. Fourth Quarter 2020 and Subsequent Event Highlights Revenue was $9.9 million Net loss attributable to common stockholders was $16.6 million or $1.30 per shar
  • 03/16/2021

New York City REIT Announces Release Date for Fourth Quarter and Full Year 2020 Results

  • NEW YORK--(BUSINESS WIRE)--New York City REIT, Inc. (NYSE: NYC) (“NYC” or the “Company”) announced today it will release its financial results for the fourth quarter and full year ended December 31, 2020 on Tuesday, March 16, 2021 before the start of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Tuesday, March 16, 2021, beginning at 11:00 a.m. ET, to discuss the fourth quarter and full year results and provide commentary on business perform
  • 02/26/2021

New York City REIT, Inc. Announces Common Stock Dividend for First Quarter 2021

  • NEW YORK--(BUSINESS WIRE)--New York City REIT, Inc. (NYSE: NYC) (“NYC”) announced today that it intends to continue to pay dividends on its shares of Class A common stock and Class B common stock at an annualized rate of $0.40 per share or $0.10 per share on a quarterly basis. NYC anticipates paying dividends authorized by its board of directors on its shares of common stock on a quarterly basis in arrears on the 15th day of the first month following the end of each fiscal quarter (unless other
  • 01/01/2021

MacKenzie Capital Management, LP announces a tender offer for Class B Shares of New York City REIT, Inc. (NYSE:NYC)

  • ORINDA, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- MacKenzie Capital Management, LP has announced a tender offer for Class B Shares (the “Shares”) of New York City REIT, Inc. The Purchasers are offering to purchase up to 65,000 Class B Shares for $6.50 per Share.
  • 12/28/2020

If You Believe In A New York City Comeback, Look Beyond The New Pure Play NYC REIT

  • COVID has decimated New York City's economy. High COVID infection rates and low office utilization rates fuel concerns about the impact of work from home on the NYC office market. NYC REIT has very low NOI margins and higher G&A expenses compared to its peers, contributing to negative cash flow generation.
  • 12/11/2020

Good News Is Bad News

  • U.S. equity markets flirted with fresh all-time highs this week following a slate of better-than-expected economic data, which has ironically thrown a political curveball into the now-stalled fiscal stimulus negotiations.
  • 08/15/2020
Unlock
NYC Ratings Summary
NYC Quant Ranking